US20140088557A1 - Infusion Pump System - Google Patents
Infusion Pump System Download PDFInfo
- Publication number
- US20140088557A1 US20140088557A1 US14/092,532 US201314092532A US2014088557A1 US 20140088557 A1 US20140088557 A1 US 20140088557A1 US 201314092532 A US201314092532 A US 201314092532A US 2014088557 A1 US2014088557 A1 US 2014088557A1
- Authority
- US
- United States
- Prior art keywords
- infusion
- site interface
- infusion site
- pump body
- infusion pump
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
- A61M5/14566—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir for receiving a piston rod of the pump
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
- A61M5/16854—Monitoring, detecting, signalling or eliminating infusion flow anomalies by monitoring line pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
- A61M2005/1581—Right-angle needle-type devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
- A61M2005/1587—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body suitable for being connected to an infusion line after insertion into a patient
Definitions
- This invention relates to infusion pump systems.
- An infusion pump may be used to infuse fluids, medication, or nutrients into a patient's body or circulatory system.
- An infusion pump is generally used intravenously, although subcutaneous, arterial and epidural infusions are occasionally used.
- Infusion pumps can reliably administer fluids in ways that would be impractically expensive or unreliable if performed manually by nursing staff. For example, infusion pumps can administer 1 mL per hour injections (too small for a drip), injections every minute, injections with repeated boluses requested by the patient up to the maximum number per hour allowed (e.g. in patient-controlled analgesia), or fluids whose volumes vary by the time of day.
- the pumps can inject controlled amounts of fluids subcutaneously (beneath the skin), or epidurally (just within the surface of the central nervous system—a very popular local spinal anesthesia for childbirth).
- infusion pumps rely on disposable infusion sets to link the pump system to an infusion site. These sets generally have a length of tubing between both ends to accommodate the patient's changes to wear position, pump maintenance and programming and to facilitate changing of the catheter system. As pump systems gradually reduce in size and complexity, the tubing becomes tangled as a result of its length making the pumps difficult to use and uncomfortable for the patient.
- a disconnectable, body-worn infusion pump system allows a more convenient attachment method for the user of a body-attached or body-worn pump.
- the device described herein may adhere to the skin of a wearer.
- the infusion pump system maintains a fluid path between the wearer and a pump. This path can be intermittently broken and re-established without replacement of the catheter within the body of the user.
- An infusion pump system includes an infusion site interface including a soft cannula for penetration of the skin when the interface is installed, and a hub that rises above the upper surface of the interface when the interface is installed, wherein the infusion site interface lacks tubing above the upper surface of the interface, and an infusion pump body, wherein the infusion pump body can be releasably connected to the infusion site interface to form a direct connection between the infusion pump body and the infusion site interface.
- the system may include an infusion site interface adhesively attached to the infusion site on a body.
- the infusion site interface may include a carrier frame having an adhesive on the upper surface, enabling temporary adhesion of the pump body to the upper surface of the carrier frame.
- the infusion site interface may include a carrier frame, wherein the carrier frame is adhesively connected to a body near an infusion site location, and the carrier frame is connected to the hub.
- the carrier frame may be connected to the hub via structural supports between the hub and an outer frame.
- the carrier frame may include a webbing.
- the system may include an adhesive on the pump body that enables temporary adhesion of the pump body to another surface.
- the exit port of the infusion pump body may connect directly to an entry port on the infusion site interface.
- the pump body may releasably connect to the infusion site interface using a locking mechanism on the hub of the infusion site interface, or may releasably connect to the infusion site interface using a guide on the hub of the infusion site interface, or may releasably connect to the infusion site interface using the penetration of a pump body exit port through an infusion site interface septum.
- the pump body exit port may include a needle.
- the infusion pump body may include a control system.
- the infusion site interface may have no tubing external to the skin of a user after installation of the infusion site interface.
- a method of operating an infusion pump system includes dispensing medicament from a medicament reservoir in a pump body through a pump body exit port into an infusion site interface, wherein there is a direct connection between the infusion pump body and the infusion site interface during the dispensing, and wherein the pump body is releasably connected to the infusion site interface.
- the pump body exit port may include a catheter that penetrates a septum of the infusion site interface.
- the catheter may include a needle.
- the pump body exit port may connect directly to an entry port on the infusion site interface.
- the pump body may releasably connect to the infusion site interface using a locking mechanism, or may releasably connect to the infusion site interface using a guide on the infusion site interface, or may releasably connect to the infusion site interface using only the penetration of the pump body exit port through an infusion site interface septum.
- the infusion site interface may be adhesively attached to the infusion site on a body.
- the pump body may be adhesively attached near the infusion site.
- the pump body may be adhesively attached to an upper surface of the infusion site interface.
- the pump body may be adhesively attached using a single layer adhesive.
- An infusion pump system includes an infusion site interface including a soft cannula for penetration of the skin when the interface is installed, a carrier frame that can be adhesively attached to a body surface, and a hub that is connected to the carrier frame and rises above the carrier frame when the interface is installed, and an infusion pump body, wherein the infusion pump body can be connected, detached, and re-connected to the infusion site interface as desired to form a direct connection between the infusion pump body and the infusion site interface.
- an infusion site interface including a soft cannula for penetration of the skin when the interface is installed, a carrier frame that can be adhesively attached to a body surface, and a hub that is connected to the carrier frame and rises above the carrier frame when the interface is installed, and an infusion pump body, wherein the infusion pump body can be connected, detached, and re-connected to the infusion site interface as desired to form a direct connection between the infusion pump body and the infusion site interface.
- An infusion pump system includes an infusion site interface including a soft cannula for penetration of the skin when the interface is installed, a carrier frame that can be adhesively attached to a body surface, and a hub that is connected to the carrier frame and rises above the carrier frame when the interface is installed, and an infusion pump body that can be releasably connected to the infusion site interface, forming a direct connection between the infusion pump body and the infusion site interface, and an adhesive surface on the infusion pump body.
- the adhesive surface may be used to attach the infusion pump body to the infusion site interface.
- the adhesive surface may be used to attach the infusion pump body near an infusion site.
- direct connection refers to a connection that does not include any tubing or similar intermediary between the two endpoints of the direct connection.
- the term “medicament” generally refers to all fluids, medication, drugs, nutrients, biomaterials, chemicals, or other materials that may be dispensed by an infusion pump.
- FIG. 1 is an illustration of an assembled and connected infusion pump system attached to a human torso.
- FIG. 2 is an illustration of an example of an infusion pump system, including an infusion pump body detached from an infusion site interface.
- FIG. 3 is a cross-sectional illustration of an assembled and connected infusion pump system.
- FIG. 4 shows an assembled view of one example of an infusion site interface.
- FIG. 5 shows a component view of one example of an infusion site interface.
- FIG. 6 is an illustration of one example of an infusion site interface.
- FIG. 7 is a cross-section view of the infusion site interface shown in FIG. 6 .
- FIG. 8 is a top view illustration of another example of an infusion site interface.
- FIG. 9A is an illustration of another example of an infusion site interface having an access port.
- FIG. 9B is an illustration of another example of an infusion site interface having an access port and a septum.
- FIG. 10 is an illustration of another example of an infusion site interface.
- FIG. 11 is an illustration of another example of an infusion site interface.
- FIG. 12A illustrates an infusion pump system 1200 which may be used with an infusion site interface such as the ones shown in FIG. 6 .
- FIGS. 12B-D are illustrations of examples of infusion pump systems with adhesives for affixing near an infusion site.
- FIGS. 13A-C are illustrations depicting steps of one method that can be used to attach an infusion pump system to an infusion site interface.
- FIGS. 13D-F are illustrations depicting steps of one method that can be used to attach an infusion pump system to an infusion site system.
- FIG. 14 depicts an alternate embodiment of an infusion pump system 1400 with a flexible neck for use with an infusion site interface.
- the infusion pump system includes an infusion pump body and an infusion site interface.
- the infusion pump body is releasably connected to the infusion site interface, and therefore there is no associated tubing between the infusion pump body and the infusion site interface.
- the infusion pump body also includes a housing that may be adhered to the skin of a user.
- FIG. 1 shows a view of an assembled infusion pump system 100 attached to a human torso.
- the infusion pump system 100 may be used to infuse a medicament directly into an infusion site.
- a complete flow path is formed from a medicament reservoir within the infusion pump system 100 to the infusion site.
- FIGS. 2-3 are illustrations of a self-contained infusion pump system including an infusion site interface.
- FIG. 2 shows a disassembled view of the infusion pump system 100 , including a pump body 102 and an infusion site interface 104 .
- FIG. 3 shows a cut-away cross-section view of the assembled infusion pump system 100 . The component parts illustrated in these views create a complete, self contained medicine infusion pump system when assembled.
- the infusion pump body has an upper housing 111 and a lower housing 112 which define a periphery in which the pump mechanisms reside.
- the lower housing 112 may be adhered to a user's skin by means of an adhesive system.
- the upper and lower housings 111 , 112 may include openings or penetrations 114 for attachment and guidance of the infusion site interface 104 to the pump body 102 . Additionally, the openings 114 may allow for installation of a reservoir contained within the pump body 102 .
- One or more buttons 113 may be used to enter user requests into the pump system.
- mechanisms that are contained in the pump body 102 may include a reservoir 118 , a drive mechanism 124 , and a control system.
- the reservoir 118 includes a distal end 128 and a proximal end 130 .
- the reservoir 118 may be cylindrical in geometry with the distal end 128 sealed by a moveable plunger 131 of matching geometry as the reservoir 118 .
- the proximal end 130 of the reservoir 118 may be closed by a reservoir septum 132 .
- the reservoir septum 132 may be formed of a self-sealing material, such as silicone or rubber.
- the proximal end 130 of the reservoir 118 may be closed by a valve or other device.
- the drive mechanism 124 may be actuated to apply pressure internal to the reservoir so that a medicament contained within the reservoir 118 may be dispensed out of the reservoir 118 .
- the medicament may be pushed through a device that pierces the reservoir septum 132 .
- the medicament may be pushed through a valve or other device at the proximal end 130 of the reservoir 118 .
- the actuation of the drive mechanism 124 may be governed by the control mechanism.
- the geometry of the reservoir 118 has been shown as cylindrical for illustrative purposes only and the reservoir 118 is geometry independent.
- a reservoir 118 containing a medicament may be installed in the pump body 102 via an opening in the pump body 114 .
- the infusion pump body may be prepared for use after installation of the infusion site interface 104 at a body location.
- the infusion pump body may be prepared for use by inserting a reservoir 118 of medicament in the infusion pump body 102 .
- a generally cylindrical and geometrically matched medicament reservoir 118 is inserted into the vacant pump cavity.
- the reservoir might be installed by separating the pump body, such as by separating upper and lower housings.
- the reservoir might be pre-loaded into the pump body, and require no user loading. Examples of medicaments that may be contained in the medicament reservoir 188 may include insulin, pain relief drugs, hormone therapy, blood pressure treatments, anti-emetics, osteoporosis treatments, or other injectable medicines or liquids.
- FIGS. 4 and 5 show assembled and component views of one example of an infusion site interface 104 .
- the infusion site interface may also be referred to as a catheter head system.
- the infusion site interface 104 provides for continuous or intermittent subcutaneous fluid infusion and is comprised of an upper housing 140 , a lower housing 142 , a hub 144 having a hollow chamber, an infusion site interface septum 146 , a catheter of biocompatible material 149 , and an O-ring 152 for sealing the exterior surface 155 of the hub 144 against the interior surface of the pump body 102 associated with the opening 114 of the pump body.
- the catheter 149 may be used for indwelling in a user after installation of the infusion site interface 104 at a location on the body.
- the catheter 149 also defines a through passage for passing a medicament from the infusion pump system into a body.
- the infusion site interface 104 provides for the continuous fluid path between the reservoir 118 and the user.
- a continuous fluid path may be formed by connecting one side of the hub 144 to the pump body.
- One side of the hub 144 may be equipped with a septum piercing device 162 that penetrates the reservoir septum 132 (shown in FIG. 3 ), enabling medicament to enter the hub.
- the medicament may enter a chamber or junction within the hub 144 .
- Medicament may flow from the hub 144 through the catheter 149 and into the user.
- the infusion site interface 104 is equipped on a side generally tangent to the septum piercing device 162 and coplanar to a user's skin.
- the biocompatible catheter 149 may be used for subcutaneous infusion of medicine to a user.
- the septum piercing device 162 of the infusion site interface 104 may initiate a pathway for medicament by penetration of the reservoir septum 132 during attachment of the pump body 102 to the infusion site interface 104 .
- medicament may traverse from the reservoir 118 through the septum piercing device 162 , through the hub 144 and catheter 149 , and into the user.
- the infusion site interface 104 may be attached to the pump system 102 by insertion of the generally cylindrical exterior surface 155 of the hub 144 of the catheter head system 104 into the geometrically matched opening 114 of the pump body 102 .
- the exterior surface of infusion site interface 104 may contain alignment features of geometry such that the infusion site interface 104 may be attached in a single orientation or discreet set of orientations into matching mating features in the pump body 102 .
- the alignment feature(s) on the exterior surface of the hub 144 may allow the infusion site interface 104 to be securely attached to the pump body 102 , preventing unintended separation of the two systems.
- the pump system 102 may attach to the infusion site interface 104 using another method or device which allows for the secure attachment of the infusion site interface 104 to the pump body 102 .
- the secure attachment may be in the form of a locking ring which securely and releasably locks the infusion site interface 104 to the pump system 102 .
- the secure attachment may be in the form of a Luer-lock connection.
- the secure attachment may be created by a mechanism or method which is detachable from the completed system, such as flexible connector.
- the secure attachment may be in the form of replaceable locking tabs on the upper housing 111 , the lower housing 112 or infusion site interface 104 .
- the tabs on the infusion site interface 104 may engage features on the pump body 102 to prevent the accidental release of the infusion site interface 104 .
- locking tabs on the pump body 102 may engage features on the infusion site interface 104 to prevent accidental releases.
- the infusion pump body may be directly connected to the infusion site interface, such that there is no tubing or other intermediate between the pump body and the infusion site interface.
- FIG. 6 shows one example of an infusion site interface 600 .
- FIG. 7 shows a cross-section view of the infusion site interface 600 shown in FIG. 6 .
- the infusion site interface 600 includes a soft cannula 602 of biocompatible material that may be inserted into the body of a user.
- the cannula 602 is attached at its upper or proximal end to an annular sealing flange 607 that forms the center of a carrier frame 640 .
- the cannula 602 also defines a central channel 620 .
- the annular sealing flange 607 may be attached coaxially to the lower or distal surface of an inner ring or hub 614 . Together, these elements provide for the creation of a continuous fluid flow path from the orifice of the hub 614 through to the cannula 602 .
- the hub 614 defines a central orifice that may be closed by a septum 630 that seals the fluid path of the hub 614 and cannula 602 from the outside world.
- the infusion site interface 600 may also include a carrier frame 640 .
- the carrier frame 640 may include as components an outer frame member 621 and one or more structural supports 624 .
- the outer frame 621 may be attached to the hub 614 by one or more structural supports 624 .
- the structural supports 624 may be configured to be radial spokes, curved supporting members, or other configurations. In various embodiments, there may be zero, one, or multiple structural supports 624 .
- the components forming the carrier frame 640 may be made of a rigid, semi-rigid, or flexible material which may be adhered to the body by a skin adhesive system.
- the carrier frame may also include a flexible mesh or other material between the hub 614 , outer frame member 621 and structural supports 624 . When present, the flexible mesh or other material may improve the adhesion of the infusion site interface 600 to a treatment location on a body. The flexible mesh may also assist in attaching, detaching, or handling the infusion site interface 600 .
- the outer frame member 621 may be of size and shape to permit convenient placement on the body.
- the outer frame member 621 may be of sufficient rigidity to maintain secure location of the cannula 602 in the body of the wearer, and act to prevent the infusion site interface 600 from changing position or detaching from the desired location.
- the outer frame member 621 may be of sufficient flexibility to maintain wearer comfort, and maintain attachment of the cannula to the wearer during the normal wear duration.
- the cannula 602 may be a biocompatible plastic tube inserted subcutaneously in the body of the wearer to create a fluid path from a pump device to a location within the body of the wearer.
- the cannula 602 may be rigidly or flexibly attached to the hub 614 of the frame.
- the cannula 602 is maintained at a location within the body of the wearer by the adhesion of the carrier frame of the adhesion site interface 600 to the body of the wearer.
- the infusion site interface may be designed such that there is no tubing that extends external of the body after the infusion site interface is in place.
- the infusion site interface may be located on a surface of a body, with a soft cannula descending to a tissue location.
- the infusion site interface may also include a carrier frame that is adhesively attached to the body, holding the infusion site interface in place, and a hub that extends above the surface of the of the carrier frame for attachment of a pump body.
- the septum 630 provides a penetrable barrier or seal from the inserted cannula 602 to the outside world.
- the septum 630 may be of a size sufficient to allow the insertion of a drug delivery needle (as described below) or a similar drug delivery conduit.
- the entry of the drug delivery conduit into the cannula 602 may be perpendicular to the skin surface or at a suitably convenient angle.
- the septum 630 may be formed of a self-sealing material such as rubber or silicone.
- the infusion site interface 600 may also include a leak detection mechanism, whereby positive indication is provided to the wearer of the infusion site system 600 that a compromise in the fluid path has occurred. This indication can be by visual or tactile means either through color change or a means for dermal stimulation at the site.
- FIG. 8 shows a top view of one embodiment of an infusion site interface 800 .
- the infusion site interface 800 shown is similar to infusion site interface 600 in FIGS. 6 and 7 , with the exception that the hub 814 is attached to the outer frame member 821 by a plurality of structural supports 824 that are curved radial spokes.
- the carrier frame may also include a flexible mesh or other material between the hub 814 , outer frame member 821 and structural supports 824 .
- FIG. 9A shows another example of an embodiment of an infusion site interface 900 .
- the infusion site interface 900 includes a central hub 904 and a cannula 902 .
- the cannula 902 may be formed of a soft biocompatible material, and is designed for insertion into the body of a user.
- the central hub 904 includes an access port 917 and locking features 921 .
- the access port 917 connects to the cannula 902 such that medicaments that pass through the access port 917 pass through and into the cannula 902 for infusion into a user.
- the locking features 921 may be used to affix an infusion pump body to the infusion site Interface.
- a covering which normally seals against the access port 917 to prevent foreign materials from entering the infusion site system 900 opens when an infusion pump body is attached to allow medicaments pumped from the infusion pump body to pass into the infusion site interface.
- the infusion site interface 900 may also include a carrier frame 907 .
- the carrier frame 907 may include an outer frame member 908 and a flexible material 911 .
- the central hub 904 may be connected to the outer frame member 908 by the flexible material 911 .
- the flexible material 911 may be formed of a mesh or other material.
- the carrier frame 907 formed by the outer frame member 908 and flexible material 911 may adhere to the body by a conventional adhesive system.
- FIG. 9B shows another example embodiment of an infusion site interface 950 , similar to the infusion site interface of FIG. 9A .
- the infusion site interface 950 shown in FIG. 9B also includes a septum 975 located on the top surface of the hub 954 .
- the access port 967 or the septum 975 may be used to supply a medicament from an infusion pump body to the cannula 952 for infusion into a user.
- FIG. 10 shows another example embodiment of an infusion site interface 1000 .
- Infusion site interface 1000 includes a hub 1004 and a carrier frame 1005 .
- the carrier frame 1005 includes an outer frame member 1008 and a flexible mesh 1006 .
- the outer frame member 1008 is affixed to the hub 1004 by the flexible mesh 1006 .
- the carrier frame 1008 may be in a rectangular shape, as shown in FIG. 10 , or may have alternate shapes, such as a circle, square, o ellipse, or may have other regular or irregular shapes.
- Adhesive may be applied to the bottom surface of the carrier frame, including the flexible mesh 1006 and the outer frame 1008 , and may be used to affix the infusion site system to a user's body.
- the hub 1004 includes an access port 1017 , a septum 1025 , and locking features 1021 .
- the locking features 1021 may be used to affix an infusion pump system to the infusion site system 1000 .
- the access port 1017 and septum 1025 connect to a cannula (not shown) such that medicaments from an infusion pump body which pass through the access port 1017 or septum 1025 pass through and into the cannula for infusion into a user.
- FIG. 11 shows another example embodiment of an infusion site interface 1100 .
- Infusion site interface 1100 includes a cannula 1103 , a central body hub 1105 , and a carrier frame 1113 .
- the cannula 1103 is attached to the central body hub 1105 , and may be accessed by an infusion pump body via a septum 1106 .
- a locking mechanism 1107 may be incorporated into the central body hub 1105 and may be used to attach an infusion pump body to the infusion site interface 1100 .
- the carrier frame 1113 may include an outer frame member 1008 which is connected to the central body hub 1105 by a structural support 1115 .
- the structural support is configured as webbing.
- the webbing may be rigid, semi-rigid, or flexible.
- the carrier frame 1113 may also include a flexible mesh or other material between the central body hub 1105 , outer frame member 1008 , and webbing 1115 .
- the carrier frame 1113 may be adhered to a user's body via the outer frame member 1117 , webbing 1115 , and if present, the optional mesh or other material.
- the central body hub 1105 may have one or more guiding members to guide an infusion pump body for attachment to the infusion pump interface 1100 .
- the skin adhesive system used with the infusion site systems described above may include a variety of systems, methods, and materials.
- the skin adhesive system may be a flexible membrane with skin compatible adhesive capable of removably securing an infusion site interface to the skin of a user.
- a flexible membrane may have a skin compatible adhesive on a first surface and a device compatible adhesive on a second surface.
- the skin adhesive system may include an adhesive composed of a single layer material that is adhesive to both the user's skin surface and the infusion site interface.
- the adhesive material may be a gel layer, a liquid layer that dries after contact, or other material. The precise size and placement of adhesive may be dependant on the application.
- the adhesion of the infusion site interface to a user's skin may also include adhesion of a carrier frame to the user's skin.
- FIGS. 12A-12D illustrate how adhesives may be used with an infusion pump body 1200 to establish a fluid path from the infusion pump system 1200 to an infusion site system without direct mechanical coupling, thereby creating a “floating” fit wherein the flexibility of the infusion pump system including the infusion pump body and the infusion site interface is greatly increased.
- FIG.12A illustrates an infusion pump body 1200 which may be used with various infusion site interfaces, such as the ones shown in FIG. 6 .
- the infusion pump body 1200 includes a casing 1210 which contains a reservoir and pumping mechanism.
- the infusion body 1200 also includes an infusion site docking area 1212 with a septum piercing device 1220 that may provide a direct fluid path from the reservoir to the infusion site interface.
- the septum piercing device 1220 also serves as the exit port of the infusion pump body.
- the pumping mechanism including the pump housing 1210 may cause a medicament in the reservoir to flow through the septum piercing device 1220 and pass into an infusion site interface.
- a connection between the infusion pump body and an infusion site interface may be created by the septum piercing device penetrating a septum of the infusion site interface. This may be accomplished without the direct attachment of the infusion pump housing 1210 to the infusion pump interface. The infusion pump body would then be able to move relative to the infusion site interface, and move as the user moved. The infusion pump body may use manual or automatic methods to establish the fluid connection after placement of the infusion pump system 1200 on the body.
- the infusion site interface and the infusion site docking area 1212 may include corresponding guiding members, such that the pump casing 1210 may be guided onto the infusion site interface. This embodiment would allow for vertical flexibility, while restricting horizontal motion between the pump body 1200 and the infusion site interface.
- the adhesive system described above may be sufficient size and capability to adhere the infusion site interface to the skin of the user. In some embodiments, the adhesive system may also have sufficient size and capability to also adhere the infusion pump body to the skin of the wearer or to the infusion site interface.
- a release liner may be used with the adhesive system. Prior to application of an adhesive, a release liner may cover exposed adhesives to prevent unintentional adhesion. Immediately before or during application, the release liner may be removed to expose the adhesive layer for use.
- FIG. 12B shows one embodiment of an adhesive system.
- the adhesive 1240 covers a portion of the bottom of the infusion pump body 1200 .
- FIG. 12C shows another embodiment of an adhesive system, in which adhesive 1250 covers the entire bottom of the infusion pump body 1200 .
- FIG. 12D shows another embodiment of an adhesive system, in which adhesive 1260 extends past the edges of the infusion pump system 1200 .
- the adhesive may be formed as a planar substrate of material to which adhesive may be applied to one or both sides.
- a first adhesive such as hydrocolloid or synthetic rubber, may be applied to the skin contacting surface for extended adhesion to human skin in all conditions.
- a second adhesive such as acrylic, synthetic rubber or any other type of adhesive that is appropriate for the characteristics of the adhesive system, may be applied to the device contacting surface.
- the adhesive system may include a flexible agent with a skin compatible adhesive on a first surface and a device compatible adhesive on a second surface.
- the variation in thickness of the carrier across the surface of adhesion is dependant on the material selected for the carrier and the mechanical properties desired.
- the carrier thickness will be in the range of 0.1 mm to 1 mm.
- a carrier frame including an adhesive patch designed to extend 2.5 cm from the periphery of an infusion site hub may, for example, have an adhesive thickness of 0.5 mm at region of contact with the infusion site interface hub, and a thickness that decreases to a thickness of 0.2 mm at the edges.
- the carrier frame of an infusion site interface may be designed to stretch, allowing greater comfort for the user and better adhesion for the device. Both linear and non-linear adhesive thickness changes are possible.
- a single adhesive layer or coating may be applied directly to skin-contacting surfaces of the infusion pump body.
- Suitable adhesives include hydrocolloid, acrylic, synthetic rubber or other type of adhesive that is appropriate for the characteristics of the device and user skin.
- the adhesive system may also include compounds to reduce or modify the discomfort associated with attachment of the infusion site interface, or the pump body to the skin.
- These compounds include, but are not limited to, compounds intended to reduce irritation, inflammation and itching.
- the compounds may be included in the manufacture of the adhesive or the carrier material, or subsequently an adhesive that is manufactured with these properties specifically integrated into the chemical composition may be applied to the device after manufacturing.
- FIGS. 13A-C depict an example of an infusion pump body 1300 with a locking attachment mechanism being attached to the infusion site interface 1000 .
- the infusion pump body 1300 is aligned with a locking collar in the infusion pump body 1300 such that locking features 1021 match up with corresponding features in the locking collar.
- Pressing the infusion pump system down onto the infusion site system causes a septum piercing device to pierce the septum 1025 .
- the attachment mechanism connecting the infusion pump body 1300 to the infusion site interface 1000 may be a Luer lock.
- FIG. 13B shows a twisting motion used to lock the infusion pump body 1300 onto the infusion site interface 1000 .
- FIG. 13C shows the complete infusion pump system including the infusion pump body 1300 locked to the infusion site interface 1000 via the locking features 1021 .
- the infusion site interface 1000 includes an adhesive on the top surface of the infusion site interface.
- the pump body 1300 would also be adhesively attached to the infusion site interface, creating a tighter connection between the components of the infusion pump system.
- the top surface of the infusion site interface 1000 and the bottom surface of the infusion pump body 1300 may include a mechanical adhesion system. In such a system, the pump body 1300 would be mechanically adhered to the infusion site interface 1000 , also creating a tighter connection.
- An example of a mechanical adhesion system that may be used includes a Velcro adhesive system, or other mechanical adhesion.
- FIGS. 13D-E depict another example of an infusion pump body 1300 with a locking attachment mechanism being attached to the infusion site interface 1000 . Similar steps to FIGS. 13A-C are shown, with a different infusion site interface.
- infusion site interface 900 is used to affix the infusion pump body 1300 to the user's body.
- an additional mesh 1305 is used to secure the infusion pump body 1300 to the user's body after attachment to the infusion site interface.
- the additional mesh 1305 may include an adhesive on the top surface for attachment to the pump body 1300 , or may include a mechanical adhesion system used in conjunction with other components on the infusion pump body 1300 .
- an infusion pump system may be attached to an infusion site system with an insert and twist method, or alternately a detent fit or user activated locking lever or securing mechanism whereby the frame of the infusion site system is mechanically coupled to the body of the infusion pump system.
- the alignment method may use guide features to connect a pump body with an infusion site interface.
- These guide features may employ geometries or shapes for the infusion site interface in which complimentary geometries and shapes are provided on the infusion pump body to maintain alignment.
- the mechanical attachment of infusion pump body to the infusion site interface 600 may be effected without mechanical locking
- the infusion site interface may include a mechanism for the alignment of the infusion pump body, with adhesion of the pump body to the skin being the only method employed to retain the exit port of the infusion pump body within the infusion site interface to maintain fluid path continuity.
- FIG. 14 depicts an alternate embodiment of an infusion pump body for use with an infusion site system.
- the infusion pump body 1400 includes a pump body reservoir section 1410 , a flexible neck 1414 , and an infusion pump head 1412 .
- the infusion pump head 1412 is used to connect to an infusion site interface, such as those described earlier.
- the flexible neck 1414 allows the pump body 1410 and infusion site interface to move semi-independently relative to each other when attached together.
- the pump body reservoir section 1410 includes a pumping mechanism 1420 and a reservoir 1430 containing a medicament to be infused.
- the reservoir 1430 is connected to an exit port 1431 on the infusion pump head 1412 such that a medicament in the reservoir may flow directly from the reservoir to an attached infusion site interface.
- the exit port 1431 may be formed of a septum piercing device.
- the infusion pump body 1400 may have a window 1421 which may be used to access the infusion site. Such a window may allow for inspection or care of the infusion site without removing the infusion pump body 1400 .
- the window 1421 may be able to be opened or moved aside, allowing for access to the infusion site or infusion site interface. For example, this might allow for injection of an additional or different medicament using the same infusion site interface.
Abstract
Description
- This application is a divisional of U.S. patent application Ser. No. 11/557,910 filed on Nov. 8, 2006, which claims the benefit of U.S. Provisional Application 60/734,382, filed Nov. 8, 2005, U.S. Provisional Application 60/758,955, filed Jan. 13, 2006, and U.S. Provisional Application 60/771,496, filed Feb. 8, 2006. The disclosures of the prior applications are considered part of and are hereby incorporated in their entirety by reference in the disclosure of this application.
- This invention relates to infusion pump systems.
- An infusion pump may be used to infuse fluids, medication, or nutrients into a patient's body or circulatory system. An infusion pump is generally used intravenously, although subcutaneous, arterial and epidural infusions are occasionally used. Infusion pumps can reliably administer fluids in ways that would be impractically expensive or unreliable if performed manually by nursing staff. For example, infusion pumps can administer 1 mL per hour injections (too small for a drip), injections every minute, injections with repeated boluses requested by the patient up to the maximum number per hour allowed (e.g. in patient-controlled analgesia), or fluids whose volumes vary by the time of day.
- As infusion pumps can also produce quite high but controlled pressures, the pumps can inject controlled amounts of fluids subcutaneously (beneath the skin), or epidurally (just within the surface of the central nervous system—a very popular local spinal anesthesia for childbirth).
- Conventional infusion pumps rely on disposable infusion sets to link the pump system to an infusion site. These sets generally have a length of tubing between both ends to accommodate the patient's changes to wear position, pump maintenance and programming and to facilitate changing of the catheter system. As pump systems gradually reduce in size and complexity, the tubing becomes tangled as a result of its length making the pumps difficult to use and uncomfortable for the patient.
- A disconnectable, body-worn infusion pump system allows a more convenient attachment method for the user of a body-attached or body-worn pump. The device described herein may adhere to the skin of a wearer. The infusion pump system maintains a fluid path between the wearer and a pump. This path can be intermittently broken and re-established without replacement of the catheter within the body of the user.
- An infusion pump system is described that includes an infusion site interface including a soft cannula for penetration of the skin when the interface is installed, and a hub that rises above the upper surface of the interface when the interface is installed, wherein the infusion site interface lacks tubing above the upper surface of the interface, and an infusion pump body, wherein the infusion pump body can be releasably connected to the infusion site interface to form a direct connection between the infusion pump body and the infusion site interface.
- The system may include an infusion site interface adhesively attached to the infusion site on a body. The infusion site interface may include a carrier frame having an adhesive on the upper surface, enabling temporary adhesion of the pump body to the upper surface of the carrier frame. The infusion site interface may include a carrier frame, wherein the carrier frame is adhesively connected to a body near an infusion site location, and the carrier frame is connected to the hub. The carrier frame may be connected to the hub via structural supports between the hub and an outer frame. The carrier frame may include a webbing.
- The system may include an adhesive on the pump body that enables temporary adhesion of the pump body to another surface. The exit port of the infusion pump body may connect directly to an entry port on the infusion site interface.
- The pump body may releasably connect to the infusion site interface using a locking mechanism on the hub of the infusion site interface, or may releasably connect to the infusion site interface using a guide on the hub of the infusion site interface, or may releasably connect to the infusion site interface using the penetration of a pump body exit port through an infusion site interface septum. The pump body exit port may include a needle.
- The infusion pump body may include a control system. The infusion site interface may have no tubing external to the skin of a user after installation of the infusion site interface.
- A method of operating an infusion pump system is described that includes dispensing medicament from a medicament reservoir in a pump body through a pump body exit port into an infusion site interface, wherein there is a direct connection between the infusion pump body and the infusion site interface during the dispensing, and wherein the pump body is releasably connected to the infusion site interface.
- The pump body exit port may include a catheter that penetrates a septum of the infusion site interface. The catheter may include a needle. The pump body exit port may connect directly to an entry port on the infusion site interface. The pump body may releasably connect to the infusion site interface using a locking mechanism, or may releasably connect to the infusion site interface using a guide on the infusion site interface, or may releasably connect to the infusion site interface using only the penetration of the pump body exit port through an infusion site interface septum.
- The infusion site interface may be adhesively attached to the infusion site on a body. The pump body may be adhesively attached near the infusion site. The pump body may be adhesively attached to an upper surface of the infusion site interface. The pump body may be adhesively attached using a single layer adhesive.
- An infusion pump system is described that includes an infusion site interface including a soft cannula for penetration of the skin when the interface is installed, a carrier frame that can be adhesively attached to a body surface, and a hub that is connected to the carrier frame and rises above the carrier frame when the interface is installed, and an infusion pump body, wherein the infusion pump body can be connected, detached, and re-connected to the infusion site interface as desired to form a direct connection between the infusion pump body and the infusion site interface.
- An infusion pump system is described that includes an infusion site interface including a soft cannula for penetration of the skin when the interface is installed, a carrier frame that can be adhesively attached to a body surface, and a hub that is connected to the carrier frame and rises above the carrier frame when the interface is installed, and an infusion pump body that can be releasably connected to the infusion site interface, forming a direct connection between the infusion pump body and the infusion site interface, and an adhesive surface on the infusion pump body.
- The adhesive surface may be used to attach the infusion pump body to the infusion site interface. The adhesive surface may be used to attach the infusion pump body near an infusion site.
- As used herein, the term “direct connection” refers to a connection that does not include any tubing or similar intermediary between the two endpoints of the direct connection.
- As used herein, the term “medicament” generally refers to all fluids, medication, drugs, nutrients, biomaterials, chemicals, or other materials that may be dispensed by an infusion pump.
- The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
-
FIG. 1 is an illustration of an assembled and connected infusion pump system attached to a human torso. -
FIG. 2 is an illustration of an example of an infusion pump system, including an infusion pump body detached from an infusion site interface. -
FIG. 3 is a cross-sectional illustration of an assembled and connected infusion pump system. -
FIG. 4 shows an assembled view of one example of an infusion site interface. -
FIG. 5 shows a component view of one example of an infusion site interface. -
FIG. 6 is an illustration of one example of an infusion site interface. -
FIG. 7 is a cross-section view of the infusion site interface shown inFIG. 6 . -
FIG. 8 is a top view illustration of another example of an infusion site interface. -
FIG. 9A is an illustration of another example of an infusion site interface having an access port. -
FIG. 9B is an illustration of another example of an infusion site interface having an access port and a septum. -
FIG. 10 is an illustration of another example of an infusion site interface. -
FIG. 11 is an illustration of another example of an infusion site interface. -
FIG. 12A illustrates aninfusion pump system 1200 which may be used with an infusion site interface such as the ones shown inFIG. 6 . -
FIGS. 12B-D are illustrations of examples of infusion pump systems with adhesives for affixing near an infusion site. -
FIGS. 13A-C are illustrations depicting steps of one method that can be used to attach an infusion pump system to an infusion site interface. -
FIGS. 13D-F are illustrations depicting steps of one method that can be used to attach an infusion pump system to an infusion site system. -
FIG. 14 depicts an alternate embodiment of aninfusion pump system 1400 with a flexible neck for use with an infusion site interface. - Like reference symbols in the various drawings indicate like elements.
- An infusion pump system is described that increases patient comfort and convenience. The infusion pump system includes an infusion pump body and an infusion site interface. The infusion pump body is releasably connected to the infusion site interface, and therefore there is no associated tubing between the infusion pump body and the infusion site interface. The infusion pump body also includes a housing that may be adhered to the skin of a user.
-
FIG. 1 shows a view of an assembledinfusion pump system 100 attached to a human torso. Theinfusion pump system 100 may be used to infuse a medicament directly into an infusion site. A complete flow path is formed from a medicament reservoir within theinfusion pump system 100 to the infusion site. -
FIGS. 2-3 are illustrations of a self-contained infusion pump system including an infusion site interface.FIG. 2 shows a disassembled view of theinfusion pump system 100, including apump body 102 and aninfusion site interface 104.FIG. 3 shows a cut-away cross-section view of the assembledinfusion pump system 100. The component parts illustrated in these views create a complete, self contained medicine infusion pump system when assembled. - Returning to
FIG. 2 , the infusion pump body has anupper housing 111 and alower housing 112 which define a periphery in which the pump mechanisms reside. Thelower housing 112 may be adhered to a user's skin by means of an adhesive system. The upper andlower housings penetrations 114 for attachment and guidance of theinfusion site interface 104 to thepump body 102. Additionally, theopenings 114 may allow for installation of a reservoir contained within thepump body 102. One ormore buttons 113 may be used to enter user requests into the pump system. - As can be seen in
FIG. 3 , mechanisms that are contained in thepump body 102 may include areservoir 118, adrive mechanism 124, and a control system. Thereservoir 118 includes adistal end 128 and aproximal end 130. Thereservoir 118 may be cylindrical in geometry with thedistal end 128 sealed by amoveable plunger 131 of matching geometry as thereservoir 118. Theproximal end 130 of thereservoir 118 may be closed by areservoir septum 132. In some embodiments, thereservoir septum 132 may be formed of a self-sealing material, such as silicone or rubber. In other embodiments theproximal end 130 of thereservoir 118 may be closed by a valve or other device. Thedrive mechanism 124 may be actuated to apply pressure internal to the reservoir so that a medicament contained within thereservoir 118 may be dispensed out of thereservoir 118. In one embodiment, the medicament may be pushed through a device that pierces thereservoir septum 132. In other embodiments, the medicament may be pushed through a valve or other device at theproximal end 130 of thereservoir 118. The actuation of thedrive mechanism 124 may be governed by the control mechanism. The geometry of thereservoir 118 has been shown as cylindrical for illustrative purposes only and thereservoir 118 is geometry independent. - In one embodiment, a
reservoir 118 containing a medicament may be installed in thepump body 102 via an opening in thepump body 114. The infusion pump body may be prepared for use after installation of theinfusion site interface 104 at a body location. In some embodiments, the infusion pump body may be prepared for use by inserting areservoir 118 of medicament in theinfusion pump body 102. For example, a generally cylindrical and geometrically matchedmedicament reservoir 118 is inserted into the vacant pump cavity. In another embodiment, the reservoir might be installed by separating the pump body, such as by separating upper and lower housings. In another embodiment, the reservoir might be pre-loaded into the pump body, and require no user loading. Examples of medicaments that may be contained in the medicament reservoir 188 may include insulin, pain relief drugs, hormone therapy, blood pressure treatments, anti-emetics, osteoporosis treatments, or other injectable medicines or liquids. -
FIGS. 4 and 5 show assembled and component views of one example of aninfusion site interface 104. The infusion site interface may also be referred to as a catheter head system. Theinfusion site interface 104 provides for continuous or intermittent subcutaneous fluid infusion and is comprised of anupper housing 140, alower housing 142, a hub 144 having a hollow chamber, an infusionsite interface septum 146, a catheter ofbiocompatible material 149, and an O-ring 152 for sealing theexterior surface 155 of the hub 144 against the interior surface of thepump body 102 associated with theopening 114 of the pump body. Thecatheter 149 may be used for indwelling in a user after installation of theinfusion site interface 104 at a location on the body. Thecatheter 149 also defines a through passage for passing a medicament from the infusion pump system into a body. Theinfusion site interface 104 provides for the continuous fluid path between thereservoir 118 and the user. - A continuous fluid path may be formed by connecting one side of the hub 144 to the pump body. One side of the hub 144 may be equipped with a septum piercing device 162 that penetrates the reservoir septum 132 (shown in
FIG. 3 ), enabling medicament to enter the hub. In one embodiment, the medicament may enter a chamber or junction within the hub 144. Medicament may flow from the hub 144 through thecatheter 149 and into the user. Typically, theinfusion site interface 104 is equipped on a side generally tangent to the septum piercing device 162 and coplanar to a user's skin. Thebiocompatible catheter 149 may be used for subcutaneous infusion of medicine to a user. Thus, the septum piercing device 162 of theinfusion site interface 104 may initiate a pathway for medicament by penetration of thereservoir septum 132 during attachment of thepump body 102 to theinfusion site interface 104. During treatment, medicament may traverse from thereservoir 118 through the septum piercing device 162, through the hub 144 andcatheter 149, and into the user. - Referring again to
FIG. 2 , theinfusion site interface 104 may be attached to thepump system 102 by insertion of the generally cylindricalexterior surface 155 of the hub 144 of thecatheter head system 104 into the geometrically matched opening 114 of thepump body 102. In some embodiments, the exterior surface ofinfusion site interface 104 may contain alignment features of geometry such that theinfusion site interface 104 may be attached in a single orientation or discreet set of orientations into matching mating features in thepump body 102. The alignment feature(s) on the exterior surface of the hub 144 may allow theinfusion site interface 104 to be securely attached to thepump body 102, preventing unintended separation of the two systems. - In another embodiment, the
pump system 102 may attach to theinfusion site interface 104 using another method or device which allows for the secure attachment of theinfusion site interface 104 to thepump body 102. In one approach, the secure attachment may be in the form of a locking ring which securely and releasably locks theinfusion site interface 104 to thepump system 102. In another approach, the secure attachment may be in the form of a Luer-lock connection. In another approach, the secure attachment may be created by a mechanism or method which is detachable from the completed system, such as flexible connector. In another approach, the secure attachment may be in the form of replaceable locking tabs on theupper housing 111, thelower housing 112 orinfusion site interface 104. When locked, the tabs on theinfusion site interface 104 may engage features on thepump body 102 to prevent the accidental release of theinfusion site interface 104. Alternatively, locking tabs on thepump body 102 may engage features on theinfusion site interface 104 to prevent accidental releases. The infusion pump body may be directly connected to the infusion site interface, such that there is no tubing or other intermediate between the pump body and the infusion site interface. -
FIG. 6 shows one example of aninfusion site interface 600.FIG. 7 shows a cross-section view of theinfusion site interface 600 shown inFIG. 6 . - The
infusion site interface 600 includes asoft cannula 602 of biocompatible material that may be inserted into the body of a user. Thecannula 602 is attached at its upper or proximal end to anannular sealing flange 607 that forms the center of acarrier frame 640. Thecannula 602 also defines acentral channel 620. Theannular sealing flange 607 may be attached coaxially to the lower or distal surface of an inner ring orhub 614. Together, these elements provide for the creation of a continuous fluid flow path from the orifice of thehub 614 through to thecannula 602. These elements may also form the confines of an intermediate chamber in thehub 614 that connects to the channel 320 in thecannula 602. Thehub 614 defines a central orifice that may be closed by aseptum 630 that seals the fluid path of thehub 614 andcannula 602 from the outside world. - The
infusion site interface 600 may also include acarrier frame 640. Thecarrier frame 640 may include as components anouter frame member 621 and one or morestructural supports 624. Theouter frame 621 may be attached to thehub 614 by one or morestructural supports 624. Thestructural supports 624 may be configured to be radial spokes, curved supporting members, or other configurations. In various embodiments, there may be zero, one, or multiplestructural supports 624. The components forming thecarrier frame 640 may be made of a rigid, semi-rigid, or flexible material which may be adhered to the body by a skin adhesive system. The carrier frame may also include a flexible mesh or other material between thehub 614,outer frame member 621 andstructural supports 624. When present, the flexible mesh or other material may improve the adhesion of theinfusion site interface 600 to a treatment location on a body. The flexible mesh may also assist in attaching, detaching, or handling theinfusion site interface 600. - The
outer frame member 621 may be of size and shape to permit convenient placement on the body. Theouter frame member 621 may be of sufficient rigidity to maintain secure location of thecannula 602 in the body of the wearer, and act to prevent theinfusion site interface 600 from changing position or detaching from the desired location. Theouter frame member 621 may be of sufficient flexibility to maintain wearer comfort, and maintain attachment of the cannula to the wearer during the normal wear duration. - The
cannula 602 may be a biocompatible plastic tube inserted subcutaneously in the body of the wearer to create a fluid path from a pump device to a location within the body of the wearer. Thecannula 602 may be rigidly or flexibly attached to thehub 614 of the frame. Generally, thecannula 602 is maintained at a location within the body of the wearer by the adhesion of the carrier frame of theadhesion site interface 600 to the body of the wearer. The infusion site interface may be designed such that there is no tubing that extends external of the body after the infusion site interface is in place. Thus, the infusion site interface may be located on a surface of a body, with a soft cannula descending to a tissue location. The infusion site interface may also include a carrier frame that is adhesively attached to the body, holding the infusion site interface in place, and a hub that extends above the surface of the of the carrier frame for attachment of a pump body. - The
septum 630 provides a penetrable barrier or seal from the insertedcannula 602 to the outside world. Theseptum 630 may be of a size sufficient to allow the insertion of a drug delivery needle (as described below) or a similar drug delivery conduit. The entry of the drug delivery conduit into thecannula 602 may be perpendicular to the skin surface or at a suitably convenient angle. Theseptum 630 may be formed of a self-sealing material such as rubber or silicone. - The
infusion site interface 600 may also include a leak detection mechanism, whereby positive indication is provided to the wearer of theinfusion site system 600 that a compromise in the fluid path has occurred. This indication can be by visual or tactile means either through color change or a means for dermal stimulation at the site. -
FIG. 8 shows a top view of one embodiment of aninfusion site interface 800. Theinfusion site interface 800 shown is similar toinfusion site interface 600 inFIGS. 6 and 7 , with the exception that thehub 814 is attached to theouter frame member 821 by a plurality ofstructural supports 824 that are curved radial spokes. In some embodiments, the carrier frame may also include a flexible mesh or other material between thehub 814,outer frame member 821 andstructural supports 824. -
FIG. 9A shows another example of an embodiment of aninfusion site interface 900. Theinfusion site interface 900 includes a central hub 904 and a cannula 902. The cannula 902 may be formed of a soft biocompatible material, and is designed for insertion into the body of a user. The central hub 904 includes an access port 917 and locking features 921. The access port 917 connects to the cannula 902 such that medicaments that pass through the access port 917 pass through and into the cannula 902 for infusion into a user. The locking features 921 may be used to affix an infusion pump body to the infusion site Interface. A covering which normally seals against the access port 917 to prevent foreign materials from entering theinfusion site system 900 opens when an infusion pump body is attached to allow medicaments pumped from the infusion pump body to pass into the infusion site interface. - The
infusion site interface 900 may also include a carrier frame 907. The carrier frame 907 may include an outer frame member 908 and a flexible material 911. The central hub 904 may be connected to the outer frame member 908 by the flexible material 911. The flexible material 911 may be formed of a mesh or other material. The carrier frame 907 formed by the outer frame member 908 and flexible material 911 may adhere to the body by a conventional adhesive system. -
FIG. 9B shows another example embodiment of an infusion site interface 950, similar to the infusion site interface ofFIG. 9A . The infusion site interface 950 shown inFIG. 9B also includes a septum 975 located on the top surface of the hub 954. In this embodiment, the access port 967 or the septum 975 may be used to supply a medicament from an infusion pump body to the cannula 952 for infusion into a user. -
FIG. 10 shows another example embodiment of aninfusion site interface 1000.Infusion site interface 1000 includes ahub 1004 and acarrier frame 1005. Thecarrier frame 1005 includes anouter frame member 1008 and aflexible mesh 1006. Theouter frame member 1008 is affixed to thehub 1004 by theflexible mesh 1006. Thecarrier frame 1008 may be in a rectangular shape, as shown inFIG. 10 , or may have alternate shapes, such as a circle, square, o ellipse, or may have other regular or irregular shapes. Adhesive may be applied to the bottom surface of the carrier frame, including theflexible mesh 1006 and theouter frame 1008, and may be used to affix the infusion site system to a user's body. - The
hub 1004 includes anaccess port 1017, aseptum 1025, and locking features 1021. The locking features 1021 may be used to affix an infusion pump system to theinfusion site system 1000. Theaccess port 1017 andseptum 1025 connect to a cannula (not shown) such that medicaments from an infusion pump body which pass through theaccess port 1017 orseptum 1025 pass through and into the cannula for infusion into a user. -
FIG. 11 shows another example embodiment of an infusion site interface 1100. Infusion site interface 1100 includes acannula 1103, acentral body hub 1105, and acarrier frame 1113. Thecannula 1103 is attached to thecentral body hub 1105, and may be accessed by an infusion pump body via aseptum 1106. Alocking mechanism 1107 may be incorporated into thecentral body hub 1105 and may be used to attach an infusion pump body to the infusion site interface 1100. Thecarrier frame 1113 may include anouter frame member 1008 which is connected to thecentral body hub 1105 by astructural support 1115. In this embodiment, the structural support is configured as webbing. The webbing may be rigid, semi-rigid, or flexible. In some embodiments, thecarrier frame 1113 may also include a flexible mesh or other material between thecentral body hub 1105,outer frame member 1008, andwebbing 1115. Thecarrier frame 1113 may be adhered to a user's body via theouter frame member 1117,webbing 1115, and if present, the optional mesh or other material. In other embodiments, thecentral body hub 1105 may have one or more guiding members to guide an infusion pump body for attachment to the infusion pump interface 1100. - The skin adhesive system used with the infusion site systems described above may include a variety of systems, methods, and materials. In one embodiment, the skin adhesive system may be a flexible membrane with skin compatible adhesive capable of removably securing an infusion site interface to the skin of a user. In another embodiment, a flexible membrane may have a skin compatible adhesive on a first surface and a device compatible adhesive on a second surface. In other embodiments, the skin adhesive system may include an adhesive composed of a single layer material that is adhesive to both the user's skin surface and the infusion site interface. Variously, the adhesive material may be a gel layer, a liquid layer that dries after contact, or other material. The precise size and placement of adhesive may be dependant on the application. Typically, the adhesion of the infusion site interface to a user's skin may also include adhesion of a carrier frame to the user's skin.
-
FIGS. 12A-12D illustrate how adhesives may be used with aninfusion pump body 1200 to establish a fluid path from theinfusion pump system 1200 to an infusion site system without direct mechanical coupling, thereby creating a “floating” fit wherein the flexibility of the infusion pump system including the infusion pump body and the infusion site interface is greatly increased. -
FIG.12A illustrates aninfusion pump body 1200 which may be used with various infusion site interfaces, such as the ones shown inFIG. 6 . Theinfusion pump body 1200 includes acasing 1210 which contains a reservoir and pumping mechanism. Theinfusion body 1200 also includes an infusionsite docking area 1212 with aseptum piercing device 1220 that may provide a direct fluid path from the reservoir to the infusion site interface. Theseptum piercing device 1220 also serves as the exit port of the infusion pump body. The pumping mechanism including thepump housing 1210 may cause a medicament in the reservoir to flow through theseptum piercing device 1220 and pass into an infusion site interface. - A connection between the infusion pump body and an infusion site interface may be created by the septum piercing device penetrating a septum of the infusion site interface. This may be accomplished without the direct attachment of the
infusion pump housing 1210 to the infusion pump interface. The infusion pump body would then be able to move relative to the infusion site interface, and move as the user moved. The infusion pump body may use manual or automatic methods to establish the fluid connection after placement of theinfusion pump system 1200 on the body. In some embodiments the infusion site interface and the infusionsite docking area 1212 may include corresponding guiding members, such that thepump casing 1210 may be guided onto the infusion site interface. This embodiment would allow for vertical flexibility, while restricting horizontal motion between thepump body 1200 and the infusion site interface. - The adhesive system described above may be sufficient size and capability to adhere the infusion site interface to the skin of the user. In some embodiments, the adhesive system may also have sufficient size and capability to also adhere the infusion pump body to the skin of the wearer or to the infusion site interface. A release liner may be used with the adhesive system. Prior to application of an adhesive, a release liner may cover exposed adhesives to prevent unintentional adhesion. Immediately before or during application, the release liner may be removed to expose the adhesive layer for use.
-
FIG. 12B shows one embodiment of an adhesive system. In this adhesive system, the adhesive 1240 covers a portion of the bottom of theinfusion pump body 1200. -
FIG. 12C shows another embodiment of an adhesive system, in which adhesive 1250 covers the entire bottom of theinfusion pump body 1200. -
FIG. 12D shows another embodiment of an adhesive system, in which adhesive 1260 extends past the edges of theinfusion pump system 1200. - In some embodiments, the adhesive may be formed as a planar substrate of material to which adhesive may be applied to one or both sides. A first adhesive, such as hydrocolloid or synthetic rubber, may be applied to the skin contacting surface for extended adhesion to human skin in all conditions. A second adhesive, such as acrylic, synthetic rubber or any other type of adhesive that is appropriate for the characteristics of the adhesive system, may be applied to the device contacting surface. In some embodiments, the adhesive system may include a flexible agent with a skin compatible adhesive on a first surface and a device compatible adhesive on a second surface.
- The variation in thickness of the carrier across the surface of adhesion is dependant on the material selected for the carrier and the mechanical properties desired. In some embodiments, the carrier thickness will be in the range of 0.1 mm to 1 mm. For example, a carrier frame including an adhesive patch designed to extend 2.5 cm from the periphery of an infusion site hub may, for example, have an adhesive thickness of 0.5 mm at region of contact with the infusion site interface hub, and a thickness that decreases to a thickness of 0.2 mm at the edges. In some embodiments, the carrier frame of an infusion site interface may be designed to stretch, allowing greater comfort for the user and better adhesion for the device. Both linear and non-linear adhesive thickness changes are possible.
- In some embodiments, a single adhesive layer or coating may be applied directly to skin-contacting surfaces of the infusion pump body. Suitable adhesives include hydrocolloid, acrylic, synthetic rubber or other type of adhesive that is appropriate for the characteristics of the device and user skin.
- In various embodiments, the adhesive system may also include compounds to reduce or modify the discomfort associated with attachment of the infusion site interface, or the pump body to the skin. These compounds include, but are not limited to, compounds intended to reduce irritation, inflammation and itching. The compounds may be included in the manufacture of the adhesive or the carrier material, or subsequently an adhesive that is manufactured with these properties specifically integrated into the chemical composition may be applied to the device after manufacturing.
-
FIGS. 13A-C depict an example of aninfusion pump body 1300 with a locking attachment mechanism being attached to theinfusion site interface 1000. InFIG. 13A , theinfusion pump body 1300 is aligned with a locking collar in theinfusion pump body 1300 such that locking features 1021 match up with corresponding features in the locking collar. Pressing the infusion pump system down onto the infusion site system causes a septum piercing device to pierce theseptum 1025. In some embodiments, the attachment mechanism connecting theinfusion pump body 1300 to theinfusion site interface 1000 may be a Luer lock. -
FIG. 13B shows a twisting motion used to lock theinfusion pump body 1300 onto theinfusion site interface 1000.FIG. 13C shows the complete infusion pump system including theinfusion pump body 1300 locked to theinfusion site interface 1000 via the locking features 1021. In some embodiments, theinfusion site interface 1000 includes an adhesive on the top surface of the infusion site interface. In such a case, thepump body 1300 would also be adhesively attached to the infusion site interface, creating a tighter connection between the components of the infusion pump system. In other embodiments, the top surface of theinfusion site interface 1000 and the bottom surface of theinfusion pump body 1300 may include a mechanical adhesion system. In such a system, thepump body 1300 would be mechanically adhered to theinfusion site interface 1000, also creating a tighter connection. An example of a mechanical adhesion system that may be used includes a Velcro adhesive system, or other mechanical adhesion. -
FIGS. 13D-E depict another example of aninfusion pump body 1300 with a locking attachment mechanism being attached to theinfusion site interface 1000. Similar steps toFIGS. 13A-C are shown, with a different infusion site interface. In this example,infusion site interface 900 is used to affix theinfusion pump body 1300 to the user's body. In addition, anadditional mesh 1305 is used to secure theinfusion pump body 1300 to the user's body after attachment to the infusion site interface. In various embodiments, theadditional mesh 1305 may include an adhesive on the top surface for attachment to thepump body 1300, or may include a mechanical adhesion system used in conjunction with other components on theinfusion pump body 1300. - In some embodiments, an infusion pump system may be attached to an infusion site system with an insert and twist method, or alternately a detent fit or user activated locking lever or securing mechanism whereby the frame of the infusion site system is mechanically coupled to the body of the infusion pump system.
- In other embodiments, the alignment method may use guide features to connect a pump body with an infusion site interface. These guide features may employ geometries or shapes for the infusion site interface in which complimentary geometries and shapes are provided on the infusion pump body to maintain alignment.
- In other embodiments, the mechanical attachment of infusion pump body to the
infusion site interface 600 may be effected without mechanical locking The infusion site interface may include a mechanism for the alignment of the infusion pump body, with adhesion of the pump body to the skin being the only method employed to retain the exit port of the infusion pump body within the infusion site interface to maintain fluid path continuity. -
FIG. 14 depicts an alternate embodiment of an infusion pump body for use with an infusion site system. Theinfusion pump body 1400 includes a pumpbody reservoir section 1410, aflexible neck 1414, and aninfusion pump head 1412. Theinfusion pump head 1412 is used to connect to an infusion site interface, such as those described earlier. Theflexible neck 1414 allows thepump body 1410 and infusion site interface to move semi-independently relative to each other when attached together. The pumpbody reservoir section 1410 includes apumping mechanism 1420 and areservoir 1430 containing a medicament to be infused. Thereservoir 1430 is connected to anexit port 1431 on theinfusion pump head 1412 such that a medicament in the reservoir may flow directly from the reservoir to an attached infusion site interface. Theexit port 1431 may be formed of a septum piercing device. - In some embodiments, the
infusion pump body 1400 may have awindow 1421 which may be used to access the infusion site. Such a window may allow for inspection or care of the infusion site without removing theinfusion pump body 1400. In some embodiments, thewindow 1421 may be able to be opened or moved aside, allowing for access to the infusion site or infusion site interface. For example, this might allow for injection of an additional or different medicament using the same infusion site interface. - While several specific embodiments and variations have been described herein, it will be appreciated that other variations and modifications may be encompassed within the scope of the present invention, and that structural and functional equivalents to the various components and structures described herein will occur to those skilled in the pertinent arts. For example, the physical shape and size of the individual component parts, as described herein, are exemplary only, and other shapes and configurations will readily suggest themselves. Likewise, various ways may be found to attach the infusion site system to the pump and or to provide a separate locking mechanism. Furthermore, the configurations of the mechanisms and elements described herein are likewise exemplary only. The extent of this document should be deemed to include any device that exemplifies the concepts described herein and these and other variations and modifications that may suggest themselves to those skilled in the pertinent arts are considered to be within the spirit and scope of the present invention. Accordingly, other embodiments are within the scope of the following claims.
Claims (3)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/092,532 US20140088557A1 (en) | 2005-11-08 | 2013-11-27 | Infusion Pump System |
US14/290,682 US20150057615A1 (en) | 2005-11-08 | 2014-05-29 | Infusion Pump System |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73438205P | 2005-11-08 | 2005-11-08 | |
US75895506P | 2006-01-13 | 2006-01-13 | |
US77149606P | 2006-02-08 | 2006-02-08 | |
US11/557,910 US8475408B2 (en) | 2005-11-08 | 2006-11-08 | Infusion pump system |
US12/817,031 US8679060B2 (en) | 2005-11-08 | 2010-06-16 | Infusion pump system |
US14/092,532 US20140088557A1 (en) | 2005-11-08 | 2013-11-27 | Infusion Pump System |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/817,031 Continuation US8679060B2 (en) | 2005-11-08 | 2010-06-16 | Infusion pump system |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/290,682 Continuation-In-Part US20150057615A1 (en) | 2005-11-08 | 2014-05-29 | Infusion Pump System |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140088557A1 true US20140088557A1 (en) | 2014-03-27 |
Family
ID=37793979
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/557,910 Active 2028-09-06 US8475408B2 (en) | 2005-11-08 | 2006-11-08 | Infusion pump system |
US12/817,022 Active US8372039B2 (en) | 2005-11-08 | 2010-06-16 | Infusion pump system |
US12/817,031 Active US8679060B2 (en) | 2005-11-08 | 2010-06-16 | Infusion pump system |
US12/817,049 Active US8430847B2 (en) | 2005-11-08 | 2010-06-16 | Infusion pump system |
US14/092,532 Abandoned US20140088557A1 (en) | 2005-11-08 | 2013-11-27 | Infusion Pump System |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/557,910 Active 2028-09-06 US8475408B2 (en) | 2005-11-08 | 2006-11-08 | Infusion pump system |
US12/817,022 Active US8372039B2 (en) | 2005-11-08 | 2010-06-16 | Infusion pump system |
US12/817,031 Active US8679060B2 (en) | 2005-11-08 | 2010-06-16 | Infusion pump system |
US12/817,049 Active US8430847B2 (en) | 2005-11-08 | 2010-06-16 | Infusion pump system |
Country Status (6)
Country | Link |
---|---|
US (5) | US8475408B2 (en) |
EP (1) | EP1951340B2 (en) |
AT (1) | ATE439155T1 (en) |
DE (1) | DE602006008494D1 (en) |
DK (1) | DK1951340T4 (en) |
WO (1) | WO2007056504A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10987468B2 (en) | 2016-01-05 | 2021-04-27 | Bigfoot Biomedical, Inc. | Operating multi-modal medicine delivery systems |
US11065381B2 (en) | 2015-10-05 | 2021-07-20 | E3D A.C.A.L. | Infusion pump device and method for use thereof |
US11147914B2 (en) | 2013-07-19 | 2021-10-19 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US11464906B2 (en) | 2013-12-02 | 2022-10-11 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US11471598B2 (en) | 2015-04-29 | 2022-10-18 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
US11865299B2 (en) | 2008-08-20 | 2024-01-09 | Insulet Corporation | Infusion pump systems and methods |
Families Citing this family (302)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6564105B2 (en) | 2000-01-21 | 2003-05-13 | Medtronic Minimed, Inc. | Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data |
US8152789B2 (en) | 2001-10-23 | 2012-04-10 | Medtronic Minimed, Inc. | System and method for providing closed loop infusion formulation delivery |
US10080529B2 (en) | 2001-12-27 | 2018-09-25 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
US20080172026A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having a suspension bolus |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
USD914881S1 (en) | 2003-11-05 | 2021-03-30 | Abbott Diabetes Care Inc. | Analyte sensor electronic mount |
JP4704351B2 (en) * | 2003-11-06 | 2011-06-15 | ライフスキャン・インコーポレイテッド | Drug introduction pen with event notification means |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
US9351669B2 (en) | 2009-09-30 | 2016-05-31 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
US8475408B2 (en) | 2005-11-08 | 2013-07-02 | Asante Solutions, Inc. | Infusion pump system |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
EP1923081B1 (en) * | 2006-05-19 | 2015-07-08 | Roche Diagnostics GmbH | Attaching device for an infusion device worn on the body |
ES2323738T3 (en) * | 2006-05-19 | 2009-07-23 | F. Hoffmann-La Roche Ag | ADAPTER DEVICE FOR STRINGING A MEDICAL INSTRUMENT ON THE SKIN SURFACE. |
US9056165B2 (en) | 2006-09-06 | 2015-06-16 | Medtronic Minimed, Inc. | Intelligent therapy recommendation algorithm and method of using the same |
EP2989975B1 (en) | 2007-02-06 | 2018-06-13 | Medtronic MiniMed, Inc. | Optical systems and methods for rationmetric measurement of blood glucose concentration |
JP5517919B2 (en) | 2007-05-10 | 2014-06-11 | グルメトリクス、 インク. | Balanced non-consumable fluorescent sensor for immediate intravascular glucose measurement |
US7931621B2 (en) | 2007-05-11 | 2011-04-26 | Calibra Medical, Inc. | Infusion assembly |
EP2185218B1 (en) | 2007-08-01 | 2013-06-26 | Medingo Ltd. | Detachable portable infusion device |
US9345836B2 (en) | 2007-10-02 | 2016-05-24 | Medimop Medical Projects Ltd. | Disengagement resistant telescoping assembly and unidirectional method of assembly for such |
US7967795B1 (en) | 2010-01-19 | 2011-06-28 | Lamodel Ltd. | Cartridge interface assembly with driving plunger |
US10420880B2 (en) | 2007-10-02 | 2019-09-24 | West Pharma. Services IL, Ltd. | Key for securing components of a drug delivery system during assembly and/or transport and methods of using same |
US20090093793A1 (en) | 2007-10-02 | 2009-04-09 | Yossi Gross | External drug pump |
US9656019B2 (en) | 2007-10-02 | 2017-05-23 | Medimop Medical Projects Ltd. | Apparatuses for securing components of a drug delivery system during transport and methods of using same |
US7875022B2 (en) | 2007-12-12 | 2011-01-25 | Asante Solutions, Inc. | Portable infusion pump and media player |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
EP2254621A2 (en) * | 2008-02-04 | 2010-12-01 | Nilimedix Ltd. | Drug delivery system with wireless monitor |
US8234126B1 (en) | 2008-02-12 | 2012-07-31 | Asante Solutions, Inc. | Distribution of infusion pumps |
MX338430B (en) * | 2008-04-01 | 2016-04-14 | Deka Products Lp | Methods and systems for controlling an infusion pump. |
US8700114B2 (en) | 2008-07-31 | 2014-04-15 | Medtronic Minmed, Inc. | Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them |
US9393369B2 (en) | 2008-09-15 | 2016-07-19 | Medimop Medical Projects Ltd. | Stabilized pen injector |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
US8650937B2 (en) | 2008-09-19 | 2014-02-18 | Tandem Diabetes Care, Inc. | Solute concentration measurement device and related methods |
US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US20100217233A1 (en) * | 2009-02-20 | 2010-08-26 | Ranft Elizabeth A | Method and device to anesthetize an area |
EP2411934A2 (en) | 2009-03-25 | 2012-02-01 | DEKA Products Limited Partnership | Infusion pump methods and systems |
CA2769030C (en) | 2009-07-30 | 2016-05-10 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
EP2473963A4 (en) | 2009-08-31 | 2014-01-08 | Abbott Diabetes Care Inc | Medical devices and methods |
US10071196B2 (en) | 2012-05-15 | 2018-09-11 | West Pharma. Services IL, Ltd. | Method for selectively powering a battery-operated drug-delivery device and device therefor |
USD810279S1 (en) | 2009-09-15 | 2018-02-13 | Medimop Medical Projects Ltd. | Injector device |
US10071198B2 (en) | 2012-11-02 | 2018-09-11 | West Pharma. Servicees IL, Ltd. | Adhesive structure for medical device |
US8157769B2 (en) | 2009-09-15 | 2012-04-17 | Medimop Medical Projects Ltd. | Cartridge insertion assembly for drug delivery system |
US8070723B2 (en) | 2009-12-31 | 2011-12-06 | Medtronic Minimed, Inc. | Activity guard |
US8348898B2 (en) | 2010-01-19 | 2013-01-08 | Medimop Medical Projects Ltd. | Automatic needle for drug pump |
USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
EP2549918B2 (en) | 2010-03-24 | 2023-01-25 | Abbott Diabetes Care, Inc. | Medical device inserters and processes of inserting and using medical devices |
EP2569031B1 (en) | 2010-05-10 | 2017-10-11 | Medimop Medical Projects Ltd. | Low volume accurate injector |
US9215995B2 (en) | 2010-06-23 | 2015-12-22 | Medtronic Minimed, Inc. | Sensor systems having multiple probes and electrode arrays |
US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US8915879B2 (en) | 2010-09-24 | 2014-12-23 | Perqflo, Llc | Infusion pumps |
US9498573B2 (en) * | 2010-09-24 | 2016-11-22 | Perqflo, Llc | Infusion pumps |
US9381300B2 (en) | 2010-09-24 | 2016-07-05 | Perqflo, Llc | Infusion pumps |
US9216249B2 (en) | 2010-09-24 | 2015-12-22 | Perqflo, Llc | Infusion pumps |
US8905972B2 (en) | 2010-11-20 | 2014-12-09 | Perqflo, Llc | Infusion pumps |
US8628510B2 (en) | 2010-12-22 | 2014-01-14 | Medtronic Minimed, Inc. | Monitoring the operating health of a force sensor in a fluid infusion device |
US8864726B2 (en) | 2011-02-22 | 2014-10-21 | Medtronic Minimed, Inc. | Pressure vented fluid reservoir having a movable septum |
US11266823B2 (en) | 2011-02-22 | 2022-03-08 | Medtronic Minimed, Inc. | Retractable sealing assembly for a fluid reservoir of a fluid infusion device |
USD702834S1 (en) | 2011-03-22 | 2014-04-15 | Medimop Medical Projects Ltd. | Cartridge for use in injection device |
US9008744B2 (en) | 2011-05-06 | 2015-04-14 | Medtronic Minimed, Inc. | Method and apparatus for continuous analyte monitoring |
US8795231B2 (en) | 2011-05-10 | 2014-08-05 | Medtronic Minimed, Inc. | Automated reservoir fill system |
CA2850148C (en) | 2011-09-27 | 2020-02-25 | Glumetrics, Inc. | Method for functionalizing a porous membrane covering of an optical sensor to facilitate coupling of an antithrombogenic agent |
US9989522B2 (en) | 2011-11-01 | 2018-06-05 | Medtronic Minimed, Inc. | Methods and materials for modulating start-up time and air removal in dry sensors |
US8999720B2 (en) | 2011-11-17 | 2015-04-07 | Medtronic Minimed, Inc. | Aqueous radiation protecting formulations and methods for making and using them |
EP4056105B1 (en) | 2011-12-11 | 2023-10-11 | Abbott Diabetes Care, Inc. | Analyte sensor devices |
CN104245032A (en) * | 2011-12-16 | 2014-12-24 | 因赛特拉医药公司 | Catheter securement devices |
US9610401B2 (en) | 2012-01-13 | 2017-04-04 | Medtronic Minimed, Inc. | Infusion set component with modular fluid channel element |
AU2013209630A1 (en) | 2012-01-19 | 2014-07-03 | Insightra Medical Incorporated | Catheter securement devices |
WO2013115843A1 (en) | 2012-01-31 | 2013-08-08 | Medimop Medical Projects Ltd. | Time dependent drug delivery apparatus |
US10668213B2 (en) | 2012-03-26 | 2020-06-02 | West Pharma. Services IL, Ltd. | Motion activated mechanisms for a drug delivery device |
US9463280B2 (en) | 2012-03-26 | 2016-10-11 | Medimop Medical Projects Ltd. | Motion activated septum puncturing drug delivery device |
US9072827B2 (en) | 2012-03-26 | 2015-07-07 | Medimop Medical Projects Ltd. | Fail safe point protector for needle safety flap |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9493807B2 (en) | 2012-05-25 | 2016-11-15 | Medtronic Minimed, Inc. | Foldover sensors and methods for making and using them |
US10156543B2 (en) | 2012-06-08 | 2018-12-18 | Medtronic Minimed, Inc. | Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods |
US9682188B2 (en) | 2012-08-21 | 2017-06-20 | Medtronic Minimed, Inc. | Reservoir fluid volume estimator and medical device incorporating same |
US10130767B2 (en) | 2012-08-30 | 2018-11-20 | Medtronic Minimed, Inc. | Sensor model supervisor for a closed-loop insulin infusion system |
US9662445B2 (en) | 2012-08-30 | 2017-05-30 | Medtronic Minimed, Inc. | Regulating entry into a closed-loop operating mode of an insulin infusion system |
WO2014074621A1 (en) | 2012-11-07 | 2014-05-15 | Glumetrics, Inc. | Dry insertion and one-point in vivo calibration of an optical analyte sensor |
US9265455B2 (en) | 2012-11-13 | 2016-02-23 | Medtronic Minimed, Inc. | Methods and systems for optimizing sensor function by the application of voltage |
US10194840B2 (en) | 2012-12-06 | 2019-02-05 | Medtronic Minimed, Inc. | Microarray electrodes useful with analyte sensors and methods for making and using them |
US9421323B2 (en) | 2013-01-03 | 2016-08-23 | Medimop Medical Projects Ltd. | Door and doorstop for portable one use drug delivery apparatus |
US10426383B2 (en) | 2013-01-22 | 2019-10-01 | Medtronic Minimed, Inc. | Muting glucose sensor oxygen response and reducing electrode edge growth with pulsed current plating |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US8920381B2 (en) * | 2013-04-12 | 2014-12-30 | Medtronic Minimed, Inc. | Infusion set with improved bore configuration |
US9011164B2 (en) | 2013-04-30 | 2015-04-21 | Medimop Medical Projects Ltd. | Clip contact for easy installation of printed circuit board PCB |
US9889256B2 (en) | 2013-05-03 | 2018-02-13 | Medimop Medical Projects Ltd. | Sensing a status of an infuser based on sensing motor control and power input |
US9338819B2 (en) | 2013-05-29 | 2016-05-10 | Medtronic Minimed, Inc. | Variable data usage personal medical system and method |
US9889252B2 (en) * | 2013-06-14 | 2018-02-13 | Medtronic, Inc. | Infusion device assembly |
US10194864B2 (en) | 2013-06-21 | 2019-02-05 | Medtronic Minimed, Inc. | Anchoring apparatus and method for attaching device on body |
US9880528B2 (en) | 2013-08-21 | 2018-01-30 | Medtronic Minimed, Inc. | Medical devices and related updating methods and systems |
US8979808B1 (en) | 2013-10-14 | 2015-03-17 | Medtronic Minimed, Inc. | On-body injector and method of use |
US9375537B2 (en) | 2013-10-14 | 2016-06-28 | Medtronic Minimed, Inc. | Therapeutic agent injection device |
US8979799B1 (en) | 2013-10-14 | 2015-03-17 | Medtronic Minimed, Inc. | Electronic injector |
US9265881B2 (en) | 2013-10-14 | 2016-02-23 | Medtronic Minimed, Inc. | Therapeutic agent injection device |
WO2015061693A1 (en) | 2013-10-24 | 2015-04-30 | Trustees Of Boston University | Infusion system employing an infusion set for preventing mischanneling of multiple medicaments |
US9226709B2 (en) | 2013-11-04 | 2016-01-05 | Medtronic Minimed, Inc. | ICE message system and method |
US9267875B2 (en) | 2013-11-21 | 2016-02-23 | Medtronic Minimed, Inc. | Accelerated life testing device and method |
US9750877B2 (en) | 2013-12-11 | 2017-09-05 | Medtronic Minimed, Inc. | Predicted time to assess and/or control a glycemic state |
US10105488B2 (en) | 2013-12-12 | 2018-10-23 | Medtronic Minimed, Inc. | Predictive infusion device operations and related methods and systems |
US9849240B2 (en) | 2013-12-12 | 2017-12-26 | Medtronic Minimed, Inc. | Data modification for predictive operations and devices incorporating same |
US20150164385A1 (en) | 2013-12-16 | 2015-06-18 | Medtronic Minimed, Inc. | Methods and systems for improving the reliability of orthogonally redundant sensors |
US10321844B2 (en) | 2013-12-16 | 2019-06-18 | Medtronic Minimed, Inc. | In-vivo electrochemical impedance spectroscopy (EIS)-based calibration |
US9779226B2 (en) | 2013-12-18 | 2017-10-03 | Medtronic Minimed, Inc. | Fingerprint enhanced authentication for medical devices in wireless networks |
US9143941B2 (en) | 2013-12-18 | 2015-09-22 | Medtronic Minimed, Inc. | Secure communication by user selectable communication range |
US9694132B2 (en) | 2013-12-19 | 2017-07-04 | Medtronic Minimed, Inc. | Insertion device for insertion set |
US9861748B2 (en) | 2014-02-06 | 2018-01-09 | Medtronic Minimed, Inc. | User-configurable closed-loop notifications and infusion systems incorporating same |
US9388805B2 (en) | 2014-03-24 | 2016-07-12 | Medtronic Minimed, Inc. | Medication pump test device and method of use |
US9689830B2 (en) | 2014-04-03 | 2017-06-27 | Medtronic Minimed, Inc. | Sensor detection pads with integrated fuse |
US9707336B2 (en) | 2014-04-07 | 2017-07-18 | Medtronic Minimed, Inc. | Priming detection system and method of using the same |
US10232113B2 (en) | 2014-04-24 | 2019-03-19 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for regulating insulin on board |
US9681828B2 (en) | 2014-05-01 | 2017-06-20 | Medtronic Minimed, Inc. | Physiological characteristic sensors and methods for forming such sensors |
WO2015177652A1 (en) | 2014-05-20 | 2015-11-26 | Cequr Sa | Medicine delivery device with restricted access filling port |
US9901305B2 (en) | 2014-06-13 | 2018-02-27 | Medtronic Minimed, Inc. | Physiological sensor history backfill system and method |
US11185627B2 (en) | 2014-07-21 | 2021-11-30 | Medtronic Minimed, Inc. | Smart connection interface |
US9717845B2 (en) | 2014-08-19 | 2017-08-01 | Medtronic Minimed, Inc. | Geofencing for medical devices |
US20160051755A1 (en) | 2014-08-25 | 2016-02-25 | Medtronic Minimed, Inc. | Low cost fluid delivery device |
US9839753B2 (en) | 2014-09-26 | 2017-12-12 | Medtronic Minimed, Inc. | Systems for managing reservoir chamber pressure |
US10159786B2 (en) | 2014-09-30 | 2018-12-25 | Perqflo, Llc | Hybrid ambulatory infusion pumps |
US10279126B2 (en) | 2014-10-07 | 2019-05-07 | Medtronic Minimed, Inc. | Fluid conduit assembly with gas trapping filter in the fluid flow path |
US9841014B2 (en) | 2014-10-20 | 2017-12-12 | Medtronic Minimed, Inc. | Insulin pump data acquisition device and system |
US9592335B2 (en) | 2014-10-20 | 2017-03-14 | Medtronic Minimed, Inc. | Insulin pump data acquisition device |
US9901675B2 (en) | 2014-11-25 | 2018-02-27 | Medtronic Minimed, Inc. | Infusion set insertion device and method of use |
US9731067B2 (en) | 2014-11-25 | 2017-08-15 | Medtronic Minimed, Inc. | Mechanical injection pump and method of use |
US9636453B2 (en) | 2014-12-04 | 2017-05-02 | Medtronic Minimed, Inc. | Advance diagnosis of infusion device operating mode viability |
US9943645B2 (en) | 2014-12-04 | 2018-04-17 | Medtronic Minimed, Inc. | Methods for operating mode transitions and related infusion devices and systems |
US10307535B2 (en) | 2014-12-19 | 2019-06-04 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for preemptive alerting |
US9717848B2 (en) | 2015-01-22 | 2017-08-01 | Medtronic Minimed, Inc. | Data derived pre-bolus delivery |
EP3650060B1 (en) | 2015-02-18 | 2021-09-29 | Medtronic Minimed, Inc. | Ambulatory infusion pumps and reservoir assemblies for use with same |
US9872954B2 (en) | 2015-03-02 | 2018-01-23 | Medtronic Minimed, Inc. | Belt clip |
US9795534B2 (en) | 2015-03-04 | 2017-10-24 | Medimop Medical Projects Ltd. | Compliant coupling assembly for cartridge coupling of a drug delivery device |
US10251813B2 (en) * | 2015-03-04 | 2019-04-09 | West Pharma. Services IL, Ltd. | Flexibly mounted cartridge alignment collar for drug delivery device |
US10307528B2 (en) | 2015-03-09 | 2019-06-04 | Medtronic Minimed, Inc. | Extensible infusion devices and related methods |
US10449298B2 (en) | 2015-03-26 | 2019-10-22 | Medtronic Minimed, Inc. | Fluid injection devices and related methods |
US9744297B2 (en) | 2015-04-10 | 2017-08-29 | Medimop Medical Projects Ltd. | Needle cannula position as an input to operational control of an injection device |
US10293120B2 (en) | 2015-04-10 | 2019-05-21 | West Pharma. Services IL, Ltd. | Redundant injection device status indication |
US10130757B2 (en) | 2015-05-01 | 2018-11-20 | Medtronic Minimed, Inc. | Method and system for leakage detection in portable medical devices |
CA2984939A1 (en) | 2015-05-14 | 2016-11-17 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
US9999721B2 (en) | 2015-05-26 | 2018-06-19 | Medtronic Minimed, Inc. | Error handling in infusion devices with distributed motor control and related operating methods |
US10149943B2 (en) | 2015-05-29 | 2018-12-11 | West Pharma. Services IL, Ltd. | Linear rotation stabilizer for a telescoping syringe stopper driverdriving assembly |
EP3302652B1 (en) | 2015-06-04 | 2023-09-06 | Medimop Medical Projects Ltd. | Cartridge insertion for drug delivery device |
CA2991058A1 (en) | 2015-07-08 | 2017-01-12 | Trustees Of Boston University | Infusion system and components thereof |
US10293108B2 (en) | 2015-08-21 | 2019-05-21 | Medtronic Minimed, Inc. | Infusion devices and related patient ratio adjustment methods |
US10201657B2 (en) | 2015-08-21 | 2019-02-12 | Medtronic Minimed, Inc. | Methods for providing sensor site rotation feedback and related infusion devices and systems |
US10543314B2 (en) | 2015-08-21 | 2020-01-28 | Medtronic Minimed, Inc. | Personalized parameter modeling with signal calibration based on historical data |
EP3347083A1 (en) | 2015-09-09 | 2018-07-18 | B. Braun Melsungen AG | Infusion systems, connectors for use with catheter devices, and related methods |
US10576207B2 (en) | 2015-10-09 | 2020-03-03 | West Pharma. Services IL, Ltd. | Angled syringe patch injector |
US9987432B2 (en) | 2015-09-22 | 2018-06-05 | West Pharma. Services IL, Ltd. | Rotation resistant friction adapter for plunger driver of drug delivery device |
US10117992B2 (en) | 2015-09-29 | 2018-11-06 | Medtronic Minimed, Inc. | Infusion devices and related rescue detection methods |
US9992818B2 (en) | 2015-10-06 | 2018-06-05 | Medtronic Minimed, Inc. | Protocol translation device |
CN108472438B (en) | 2015-10-09 | 2022-01-28 | 西医药服务以色列分公司 | Tortuous fluid path attachment to pre-filled fluid reservoirs |
US11666702B2 (en) | 2015-10-19 | 2023-06-06 | Medtronic Minimed, Inc. | Medical devices and related event pattern treatment recommendation methods |
US9757511B2 (en) | 2015-10-19 | 2017-09-12 | Medtronic Minimed, Inc. | Personal medical device and method of use with restricted mode challenge |
US11501867B2 (en) | 2015-10-19 | 2022-11-15 | Medtronic Minimed, Inc. | Medical devices and related event pattern presentation methods |
US10146911B2 (en) | 2015-10-23 | 2018-12-04 | Medtronic Minimed, Inc. | Medical devices and related methods and systems for data transfer |
US10037722B2 (en) | 2015-11-03 | 2018-07-31 | Medtronic Minimed, Inc. | Detecting breakage in a display element |
US10827959B2 (en) | 2015-11-11 | 2020-11-10 | Medtronic Minimed, Inc. | Sensor set |
US9848805B2 (en) | 2015-12-18 | 2017-12-26 | Medtronic Minimed, Inc. | Biostable glucose permeable polymer |
US10327680B2 (en) | 2015-12-28 | 2019-06-25 | Medtronic Minimed, Inc. | Sensor systems, devices, and methods for continuous glucose monitoring |
US10349872B2 (en) | 2015-12-28 | 2019-07-16 | Medtronic Minimed, Inc. | Methods, systems, and devices for sensor fusion |
US10327686B2 (en) | 2015-12-28 | 2019-06-25 | Medtronic Minimed, Inc. | Sensor systems, devices, and methods for continuous glucose monitoring |
US20170181672A1 (en) | 2015-12-28 | 2017-06-29 | Medtronic Minimed, Inc. | Sensor systems, devices, and methods for continuous glucose monitoring |
JP6542481B2 (en) | 2016-01-21 | 2019-07-10 | ウェスト ファーマ サービシーズ イスラエル リミテッド | system |
CN111544704B (en) | 2016-01-21 | 2022-06-03 | 西医药服务以色列有限公司 | Force containment in autoinjectors |
JP6885960B2 (en) | 2016-01-21 | 2021-06-16 | ウェスト ファーマ サービシーズ イスラエル リミテッド | Drug delivery device with visual indicators |
US10790054B1 (en) | 2016-12-07 | 2020-09-29 | Medtronic Minimed, Inc. | Method and apparatus for tracking of food intake and other behaviors and providing relevant feedback |
CN113035322A (en) | 2016-01-28 | 2021-06-25 | 克鲁有限公司 | Method and apparatus for tracking food intake and other behaviors and providing relevant feedback |
EP3413954A1 (en) | 2016-02-12 | 2018-12-19 | Perqflo, LLC | Ambulatory infusion pumps and assemblies for use with same |
US11389597B2 (en) | 2016-03-16 | 2022-07-19 | West Pharma. Services IL, Ltd. | Staged telescopic screw assembly having different visual indicators |
US10765348B2 (en) | 2016-04-08 | 2020-09-08 | Medtronic Minimed, Inc. | Sensor and transmitter product |
US10765369B2 (en) | 2016-04-08 | 2020-09-08 | Medtronic Minimed, Inc. | Analyte sensor |
US10420508B2 (en) | 2016-04-08 | 2019-09-24 | Medtronic Minimed, Inc. | Sensor connections |
US10589038B2 (en) | 2016-04-27 | 2020-03-17 | Medtronic Minimed, Inc. | Set connector systems for venting a fluid reservoir |
US10426389B2 (en) | 2016-04-28 | 2019-10-01 | Medtronic Minimed, Inc. | Methods, systems, and devices for electrode capacitance calculation and application |
US10324058B2 (en) | 2016-04-28 | 2019-06-18 | Medtronic Minimed, Inc. | In-situ chemistry stack for continuous glucose sensors |
US9970893B2 (en) | 2016-04-28 | 2018-05-15 | Medtronic Minimed, Inc. | Methods, systems, and devices for electrode capacitance calculation and application |
US10086133B2 (en) | 2016-05-26 | 2018-10-02 | Medtronic Minimed, Inc. | Systems for set connector assembly with lock |
US10086134B2 (en) | 2016-05-26 | 2018-10-02 | Medtronic Minimed, Inc. | Systems for set connector assembly with lock |
US9968737B2 (en) | 2016-05-26 | 2018-05-15 | Medtronic Minimed, Inc. | Systems for set connector assembly with lock |
WO2017210448A1 (en) | 2016-06-02 | 2017-12-07 | Medimop Medical Projects Ltd. | Three position needle retraction |
US11134872B2 (en) | 2016-06-06 | 2021-10-05 | Medtronic Minimed, Inc. | Thermally stable glucose limiting membrane for glucose sensors |
US11179078B2 (en) | 2016-06-06 | 2021-11-23 | Medtronic Minimed, Inc. | Polycarbonate urea/urethane polymers for use with analyte sensors |
JP6869327B2 (en) | 2016-08-01 | 2021-05-12 | ウェスト ファーマ サービシーズ イスラエル リミテッド | Anti-rotation cartridge |
EP3490635B1 (en) | 2016-08-01 | 2021-11-17 | West Pharma. Services Il, Ltd. | Partial door closure prevention spring |
EP3284507B1 (en) | 2016-08-19 | 2023-12-13 | Roche Diabetes Care GmbH | Cannula unit |
EP3290073B1 (en) | 2016-08-29 | 2020-12-09 | Roche Diabetes Care GmbH | Connector device |
US10485924B2 (en) | 2016-09-06 | 2019-11-26 | Medtronic Minimed, Inc. | Pump clip for a fluid infusion device |
EP3329956A1 (en) | 2016-11-30 | 2018-06-06 | Roche Diabetes Care GmbH | Method for manufacturing a cannula unit |
US10709834B2 (en) | 2016-12-21 | 2020-07-14 | Medtronic Minimed, Inc. | Medication fluid infusion set component with integrated physiological analyte sensor, and corresponding fluid infusion device |
US10861591B2 (en) | 2016-12-21 | 2020-12-08 | Medtronic Minimed, Inc. | Infusion systems and methods for pattern-based therapy adjustments |
US10272201B2 (en) | 2016-12-22 | 2019-04-30 | Medtronic Minimed, Inc. | Insertion site monitoring methods and related infusion devices and systems |
AU2018206409B2 (en) | 2017-01-06 | 2021-02-18 | Beta Bionics, Inc. | Infusion system and components thereof |
US11197949B2 (en) | 2017-01-19 | 2021-12-14 | Medtronic Minimed, Inc. | Medication infusion components and systems |
US10821225B2 (en) | 2017-01-20 | 2020-11-03 | Medtronic Minimed, Inc. | Cannulas for drug delivery devices |
CN110461217B (en) | 2017-01-23 | 2022-09-16 | 雅培糖尿病护理公司 | Systems, devices, and methods for analyte sensor insertion |
US10552580B2 (en) | 2017-02-07 | 2020-02-04 | Medtronic Minimed, Inc. | Infusion system consumables and related calibration methods |
US10646649B2 (en) | 2017-02-21 | 2020-05-12 | Medtronic Minimed, Inc. | Infusion devices and fluid identification apparatuses and methods |
US11134868B2 (en) | 2017-03-17 | 2021-10-05 | Medtronic Minimed, Inc. | Metal pillar device structures and methods for making and using them in electrochemical and/or electrocatalytic applications |
US11000236B2 (en) | 2017-03-24 | 2021-05-11 | Medtronic Minimed, Inc. | Patient data management systems and conversational interaction methods |
WO2018184012A1 (en) | 2017-03-31 | 2018-10-04 | Capillary Biomedical, Inc. | Helical insertion infusion device |
US11512384B2 (en) | 2017-05-11 | 2022-11-29 | Medtronic Minimed, Inc. | Analyte sensors and methods for fabricating analyte sensors |
JP6921997B2 (en) | 2017-05-30 | 2021-08-18 | ウェスト ファーマ サービシーズ イスラエル リミテッド | Modular drive train for wearable syringes |
US10856784B2 (en) | 2017-06-30 | 2020-12-08 | Medtronic Minimed, Inc. | Sensor initialization methods for faster body sensor response |
US10596295B2 (en) | 2017-08-28 | 2020-03-24 | Medtronic Minimed, Inc. | Adhesive patch arrangement for a physiological characteristic sensor, and related sensor assembly |
US11412960B2 (en) | 2017-08-28 | 2022-08-16 | Medtronic Minimed, Inc. | Pedestal for sensor assembly packaging and sensor introducer removal |
US11311217B2 (en) | 2017-09-13 | 2022-04-26 | Medtronic Minimed, Inc. | Methods, systems, and devices for calibration and optimization of glucose sensors and sensor output |
US10874300B2 (en) | 2017-09-26 | 2020-12-29 | Medtronic Minimed, Inc. | Waferscale physiological characteristic sensor package with integrated wireless transmitter |
US10524730B2 (en) | 2017-09-28 | 2020-01-07 | Medtronic Minimed, Inc. | Medical devices with microneedle arrays and methods for operating such medical devices |
US10525244B2 (en) | 2017-09-28 | 2020-01-07 | Medtronic Minimed, Inc. | Microneedle arrays and methods for fabricating microneedle arrays |
US11676734B2 (en) | 2017-11-15 | 2023-06-13 | Medtronic Minimed, Inc. | Patient therapy management system that leverages aggregated patient population data |
US11471082B2 (en) | 2017-12-13 | 2022-10-18 | Medtronic Minimed, Inc. | Complex redundancy in continuous glucose monitoring |
US11213230B2 (en) | 2017-12-13 | 2022-01-04 | Medtronic Minimed, Inc. | Optional sensor calibration in continuous glucose monitoring |
WO2019126421A1 (en) | 2017-12-22 | 2019-06-27 | West Pharma. Services Il., Ltd. | Injector usable with different dimension cartridges |
US11439352B2 (en) * | 2018-01-17 | 2022-09-13 | Medtronic Minimed, Inc. | Medical device with adhesive patch longevity |
US11186859B2 (en) | 2018-02-07 | 2021-11-30 | Medtronic Minimed, Inc. | Multilayer electrochemical analyte sensors and methods for making and using them |
US11583213B2 (en) | 2018-02-08 | 2023-02-21 | Medtronic Minimed, Inc. | Glucose sensor electrode design |
US11220735B2 (en) | 2018-02-08 | 2022-01-11 | Medtronic Minimed, Inc. | Methods for controlling physical vapor deposition metal film adhesion to substrates and surfaces |
US11672446B2 (en) | 2018-03-23 | 2023-06-13 | Medtronic Minimed, Inc. | Insulin delivery recommendations based on nutritional information |
US11158413B2 (en) | 2018-04-23 | 2021-10-26 | Medtronic Minimed, Inc. | Personalized closed loop medication delivery system that utilizes a digital twin of the patient |
US11147919B2 (en) | 2018-04-23 | 2021-10-19 | Medtronic Minimed, Inc. | Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system |
US20190341149A1 (en) | 2018-05-07 | 2019-11-07 | Medtronic Minimed, Inc. | Augmented reality guidance for medical devices |
US11761077B2 (en) | 2018-08-01 | 2023-09-19 | Medtronic Minimed, Inc. | Sputtering techniques for biosensors |
US11122697B2 (en) | 2018-08-07 | 2021-09-14 | Medtronic Minimed, Inc. | Method of fabricating an electronic medical device, including overmolding an assembly with thermoplastic material |
US11021731B2 (en) | 2018-08-23 | 2021-06-01 | Medtronic Minimed, Inc. | Analyte sensing layers, analyte sensors and methods for fabricating the same |
US10828419B2 (en) | 2018-09-04 | 2020-11-10 | Medtronic Minimed, Inc. | Infusion set with pivoting metal cannula and strain relief |
US11547799B2 (en) | 2018-09-20 | 2023-01-10 | Medtronic Minimed, Inc. | Patient day planning systems and methods |
US10980942B2 (en) | 2018-09-28 | 2021-04-20 | Medtronic Minimed, Inc. | Infusion devices and related meal bolus adjustment methods |
US10894126B2 (en) | 2018-09-28 | 2021-01-19 | Medtronic Minimed, Inc. | Fluid infusion system that automatically determines and delivers a correction bolus |
US11097052B2 (en) | 2018-09-28 | 2021-08-24 | Medtronic Minimed, Inc. | Insulin infusion device with configurable target blood glucose value for automatic basal insulin delivery operation |
US11071821B2 (en) | 2018-09-28 | 2021-07-27 | Medtronic Minimed, Inc. | Insulin infusion device with efficient confirmation routine for blood glucose measurements |
US10946140B2 (en) | 2018-10-11 | 2021-03-16 | Medtronic Minimed, Inc. | Systems and methods for measurement of fluid delivery |
US20200116748A1 (en) | 2018-10-11 | 2020-04-16 | Medtronic Minimed, Inc. | Systems and methods for measurement of fluid delivery |
US20200135320A1 (en) | 2018-10-31 | 2020-04-30 | Medtronic Minimed, Inc. | Automated detection of a physical behavior event and corresponding adjustment of a medication dispensing system based on historical events |
US20200289373A1 (en) | 2018-10-31 | 2020-09-17 | Medtronic Minimed, Inc. | Automated detection of a physical behavior event and corresponding adjustment of a physiological characteristic sensor device |
US11367517B2 (en) | 2018-10-31 | 2022-06-21 | Medtronic Minimed, Inc. | Gesture-based detection of a physical behavior event based on gesture sensor data and supplemental information from at least one external source |
US11363986B2 (en) | 2018-10-31 | 2022-06-21 | Medtronic Minimed, Inc. | Automated detection of a physical behavior event and corresponding adjustment of a medication dispensing system |
US11382541B2 (en) | 2018-11-16 | 2022-07-12 | Medtronic Minimed, Inc. | Miniaturized analyte sensor |
US11540750B2 (en) | 2018-12-19 | 2023-01-03 | Medtronic Minimed, Inc | Systems and methods for physiological characteristic monitoring |
US11701467B2 (en) | 2019-02-01 | 2023-07-18 | Medtronic Minimed, Inc. | Methods and devices for occlusion detection using actuator sensors |
US11389587B2 (en) | 2019-02-06 | 2022-07-19 | Medtronic Minimed, Inc. | Patient monitoring systems and related presentation methods |
US11191899B2 (en) | 2019-02-12 | 2021-12-07 | Medtronic Minimed, Inc. | Infusion systems and related personalized bolusing methods |
US11311215B2 (en) | 2019-04-04 | 2022-04-26 | Medtronic Minimed, Inc. | Measurement of device materials using non-Faradaic electrochemical impedance spectroscopy |
US11224361B2 (en) | 2019-04-23 | 2022-01-18 | Medtronic Minimed, Inc. | Flexible physiological characteristic sensor assembly |
US11317867B2 (en) | 2019-04-23 | 2022-05-03 | Medtronic Minimed, Inc. | Flexible physiological characteristic sensor assembly |
US10939488B2 (en) | 2019-05-20 | 2021-03-02 | Medtronic Minimed, Inc. | Method and system for controlling communication between devices of a wireless body area network for an medical device system |
USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
US11844925B2 (en) | 2019-06-06 | 2023-12-19 | Medtronic Minimed, Inc. | Fluid infusion systems |
US11448611B2 (en) | 2019-07-03 | 2022-09-20 | Medtronic Minimed, Inc. | Structurally reinforced sensor and method for manufacturing the same |
DE112020003400T5 (en) | 2019-07-16 | 2022-03-31 | Beta Bionics, Inc. | OUTPATIENT INSTITUTION AND ITS COMPONENTS |
US11617828B2 (en) | 2019-07-17 | 2023-04-04 | Medtronic Minimed, Inc. | Reservoir connection interface with detectable signature |
US11718865B2 (en) | 2019-07-26 | 2023-08-08 | Medtronic Minimed, Inc. | Methods to improve oxygen delivery to implantable sensors |
US11523757B2 (en) | 2019-08-01 | 2022-12-13 | Medtronic Minimed, Inc. | Micro-pillar working electrodes design to reduce backflow of hydrogen peroxide in glucose sensor |
US11883208B2 (en) | 2019-08-06 | 2024-01-30 | Medtronic Minimed, Inc. | Machine learning-based system for estimating glucose values based on blood glucose measurements and contextual activity data |
US11617522B2 (en) | 2019-08-06 | 2023-04-04 | Medtronic Minimed, Inc. | Sensor inserter with disposal lockout state |
US11724045B2 (en) | 2019-08-21 | 2023-08-15 | Medtronic Minimed, Inc. | Connection of a stopper and piston in a fluid delivery device |
US20210060249A1 (en) | 2019-08-29 | 2021-03-04 | Medtronic Minimed, Inc. | Controlling medical infusion device operation and features based on detected patient sleeping status |
US11654235B2 (en) | 2019-09-12 | 2023-05-23 | Medtronic Minimed, Inc. | Sensor calibration using fabrication measurements |
US11565044B2 (en) | 2019-09-12 | 2023-01-31 | Medtronic Minimed, Inc. | Manufacturing controls for sensor calibration using fabrication measurements |
US11241537B2 (en) | 2019-09-20 | 2022-02-08 | Medtronic Minimed, Inc. | Contextual personalized closed-loop adjustment methods and systems |
US11213623B2 (en) | 2019-09-20 | 2022-01-04 | Medtronic Minimed, Inc. | Infusion systems and related personalized bolusing methods |
US11511099B2 (en) | 2019-10-08 | 2022-11-29 | Medtronic Minimed, Inc. | Apparatus for detecting mating of a cap with a fluid delivery device and method |
US11638545B2 (en) | 2019-10-16 | 2023-05-02 | Medtronic Minimed, Inc. | Reducing sensor foreign body response via high surface area metal structures |
US11496083B2 (en) | 2019-11-15 | 2022-11-08 | Medtronic Minimed, Inc. | Devices and methods for controlling electromechanical actuators |
US11944784B2 (en) | 2019-11-18 | 2024-04-02 | Medtronic Minimed, Inc. | Combined analyte sensor and infusion set |
US11559624B2 (en) | 2019-11-21 | 2023-01-24 | Medtronic Minimed, Inc. | Systems for wearable infusion port and associated pump |
US11324881B2 (en) | 2019-11-21 | 2022-05-10 | Medtronic Minimed, Inc. | Systems for wearable infusion port and associated pump |
US11670425B2 (en) | 2019-12-09 | 2023-06-06 | Medtronic Minimed, Inc. | Translation modeling methods and systems for simulating sensor measurements |
CN114787932A (en) | 2019-12-13 | 2022-07-22 | 美敦力迷你迈德公司 | Method and system for training a mathematical model of a user based on data received from a discrete insulin therapy system |
US11488700B2 (en) | 2019-12-13 | 2022-11-01 | Medtronic Minimed, Inc. | Medical device configuration procedure guidance responsive to detected gestures |
US11938301B2 (en) | 2019-12-13 | 2024-03-26 | Medtronic Minimed, Inc. | Controlling medication delivery system operation and features based on automatically detected muscular movements |
US11786655B2 (en) | 2019-12-13 | 2023-10-17 | Medtronic Minimed, Inc. | Context-sensitive predictive operation of a medication delivery system in response to gesture-indicated activity changes |
US11690573B2 (en) | 2019-12-18 | 2023-07-04 | Medtronic Minimed, Inc. | Systems for skin patch gravity resistance |
US11375955B2 (en) | 2019-12-18 | 2022-07-05 | Medtronic Minimed, Inc. | Systems for skin patch gravity resistance |
US11821022B2 (en) | 2019-12-23 | 2023-11-21 | Medtronic Minimed, Inc. | Ethylene oxide absorption layer for analyte sensing and method |
US11244753B2 (en) | 2020-01-30 | 2022-02-08 | Medtronic Minimed, Inc. | Activity monitoring systems and methods |
US11833327B2 (en) | 2020-03-06 | 2023-12-05 | Medtronic Minimed, Inc. | Analyte sensor configuration and calibration based on data collected from a previously used analyte sensor |
US11278661B2 (en) | 2020-03-10 | 2022-03-22 | Beta Bionics, Inc. | Infusion system and components thereof |
USD958167S1 (en) | 2020-03-23 | 2022-07-19 | Companion Medical, Inc. | Display screen with graphical user interface |
USD958817S1 (en) | 2020-03-31 | 2022-07-26 | Medtronic Minimed, Inc. | Display screen with graphical user interface |
US11596359B2 (en) | 2020-04-09 | 2023-03-07 | Medtronic Minimed, Inc. | Methods and systems for mitigating sensor error propagation |
US11690955B2 (en) | 2020-04-23 | 2023-07-04 | Medtronic Minimed, Inc. | Continuous analyte sensor quality measures and related therapy actions for an automated therapy delivery system |
US11583631B2 (en) | 2020-04-23 | 2023-02-21 | Medtronic Minimed, Inc. | Intuitive user interface features and related functionality for a therapy delivery system |
US11272884B2 (en) | 2020-06-04 | 2022-03-15 | Medtronic Minimed, Inc. | Liner for adhesive skin patch |
US11650248B2 (en) | 2020-07-28 | 2023-05-16 | Medtronic Minimed, Inc. | Electrical current measurement system |
US11445807B2 (en) | 2020-07-31 | 2022-09-20 | Medtronic Minimed, Inc. | Pump clip with tube clamp for a fluid infusion device |
US11839743B2 (en) | 2020-10-07 | 2023-12-12 | Medtronic Minimed, Inc. | Graphic user interface for automated infusate delivery |
US11737783B2 (en) | 2020-10-16 | 2023-08-29 | Medtronic Minimed, Inc. | Disposable medical device introduction system |
US11806503B2 (en) | 2020-10-29 | 2023-11-07 | Medtronic Minimed, Inc. | Removable wearable device and related attachment methods |
US11844930B2 (en) | 2020-10-29 | 2023-12-19 | Medtronic Minimed, Inc. | User-mountable electronic device with accelerometer-based activation feature |
US11534086B2 (en) | 2020-10-30 | 2022-12-27 | Medtronic Minimed, Inc. | Low-profile wearable medical device |
USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
JP2022149020A (en) | 2021-03-25 | 2022-10-06 | テルモ株式会社 | Medical solution administration device |
WO2022202280A1 (en) * | 2021-03-25 | 2022-09-29 | テルモ株式会社 | Pharmaceutical liquid administration device |
US11904146B2 (en) | 2021-06-08 | 2024-02-20 | Medtronic Minimed, Inc. | Medicine injection devices, systems, and methods for medicine administration and tracking |
US11792714B2 (en) | 2021-06-16 | 2023-10-17 | Medtronic Minimed, Inc. | Medicine administration in dynamic networks |
US11587742B1 (en) | 2021-09-02 | 2023-02-21 | Medtronic Minimed, Inc. | Ingress-tolerant input devices |
US11817285B2 (en) | 2021-09-02 | 2023-11-14 | Medtronic Minimed, Inc. | Ingress-tolerant input devices comprising sliders |
US11896447B2 (en) | 2022-03-14 | 2024-02-13 | Medtronic Minimed, Inc. | Safeguards against separation from portable medicine delivery devices |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5672167A (en) * | 1990-05-21 | 1997-09-30 | Recordati Corporation | Controlled release osmotic pump |
US6461329B1 (en) * | 2000-03-13 | 2002-10-08 | Medtronic Minimed, Inc. | Infusion site leak detection system and method of using the same |
US6537268B1 (en) * | 1998-06-18 | 2003-03-25 | Medtronic Minimed, Inc. | Medical infusion device with a source of controlled compliance |
US20030216686A1 (en) * | 2002-03-08 | 2003-11-20 | Applied Diabetes Research, Inc. | Low profile, pivotal connection infusion assembly |
US20040115068A1 (en) * | 2002-09-27 | 2004-06-17 | Steffen Hansen | Membrane pump with stretchable pump membrane |
US20040187952A1 (en) * | 2003-03-31 | 2004-09-30 | International Business Machines Corporation | Apparatus and method to enhance reservoir utilization in a medical infusion device |
US20050101933A1 (en) * | 2003-11-10 | 2005-05-12 | James Marrs | Subcutaneous infusion device and method |
US7172572B2 (en) * | 2001-10-04 | 2007-02-06 | Boston Scientific Scimed, Inc. | Manifold system for a medical device |
Family Cites Families (238)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2005A (en) * | 1841-03-16 | Improvement in the manner of constructing molds for casting butt-hinges | ||
US5338157B1 (en) | 1992-09-09 | 1999-11-02 | Sims Deltec Inc | Systems and methods for communicating with ambulat |
US2605765A (en) | 1947-06-05 | 1952-08-05 | Kollsman Paul | Automatic syringe |
GB747701A (en) | 1953-12-16 | 1956-04-11 | Lines Bros Ltd | Improvements in apparatus for controlling movements of model ships or other toys |
US3688764A (en) * | 1970-08-20 | 1972-09-05 | Bard Hamilton Co Inc | Intracutaneous injection system |
US3886938A (en) | 1973-10-23 | 1975-06-03 | Scala Anthony | Power operated fluid infusion device |
DE2513467C3 (en) | 1975-03-26 | 1979-10-31 | Siemens Ag, 1000 Berlin Und 8000 Muenchen | Device for infusing liquids into the human or animal body |
DE2812729A1 (en) | 1978-03-23 | 1979-09-27 | Michael Becker | INJECTION DEVICE FOR INTRAMUSCULAR INJECTION, PRESENTLY OF INSULIN |
US4235234A (en) * | 1978-11-30 | 1980-11-25 | Martin John K Iii | Subcutaneous injection system |
DE2906830C2 (en) | 1979-02-22 | 1981-07-16 | B. Braun Melsungen Ag, 3508 Melsungen | Device for continuous infusions |
US4265241A (en) | 1979-02-28 | 1981-05-05 | Andros Incorporated | Implantable infusion device |
US4313439A (en) | 1980-03-24 | 1982-02-02 | Biotek, Inc. | Automated, spring-powered medicament infusion system |
US4398908A (en) | 1980-11-28 | 1983-08-16 | Siposs George G | Insulin delivery system |
US4529401A (en) | 1982-01-11 | 1985-07-16 | Cardiac Pacemakers, Inc. | Ambulatory infusion pump having programmable parameters |
US4435173A (en) | 1982-03-05 | 1984-03-06 | Delta Medical Industries | Variable rate syringe pump for insulin delivery |
US4443218A (en) | 1982-09-09 | 1984-04-17 | Infusaid Corporation | Programmable implantable infusate pump |
US4493704A (en) | 1982-11-29 | 1985-01-15 | Oximetrix, Inc. | Portable fluid infusion apparatus |
US4552561A (en) | 1982-12-23 | 1985-11-12 | Alza Corporation | Body mounted pump housing and pump assembly employing the same |
US5088981A (en) | 1985-01-18 | 1992-02-18 | Howson David C | Safety enhanced device and method for effecting application of a therapeutic agent |
FR2585252B1 (en) | 1985-07-26 | 1990-06-15 | Gazuit Ste Nle Electronique | SYRINGE DRIVER |
US4734092A (en) * | 1987-02-18 | 1988-03-29 | Ivac Corporation | Ambulatory drug delivery device |
US4850817A (en) | 1987-12-01 | 1989-07-25 | Pacesetter Infusion, Ltd. | Mechanical drive system for a medication infusion system |
GB2218831A (en) | 1988-05-17 | 1989-11-22 | Mark John Newland | Personal medical apparatus |
FR2637370B1 (en) | 1988-10-04 | 1991-04-12 | Gir | DEVICE FOR CONTROLLING TEMPERATURES CONTAINING AT LEAST ONE SHAPE MEMORY ALLOY ELEMENT |
US5190522A (en) | 1989-01-20 | 1993-03-02 | Institute Of Biocybernetics And Biomedical Engineering P.A.S. | Device for monitoring the operation of a delivery system and the method of use thereof |
US5656032A (en) * | 1989-06-16 | 1997-08-12 | Science Incorporated | Fluid delivery apparatus and method of making same |
US5045064A (en) | 1990-06-01 | 1991-09-03 | Infusaid, Inc. | Constant pressure implantable pump reservoir |
US5209230A (en) † | 1990-10-19 | 1993-05-11 | Nellcor Incorporated | Adhesive pulse oximeter sensor with reusable portion |
AU641206B2 (en) | 1991-01-22 | 1993-09-16 | Eli Lilly And Company | Multiple dose injection pen |
US5250027A (en) | 1991-10-08 | 1993-10-05 | Sherwood Medical Company | Peristaltic infusion device with backpack sensor |
DK68991D0 (en) | 1991-04-17 | 1991-04-17 | Novo Nordisk As | HEADER |
US5984894A (en) | 1991-04-18 | 1999-11-16 | Novo Nordisk A/S | Infuser |
DK69491D0 (en) | 1991-04-18 | 1991-04-18 | Novo Nordisk As | PUMP |
DK175491D0 (en) | 1991-10-18 | 1991-10-18 | Novo Nordisk As | APPARATUS |
US5852803A (en) | 1992-03-20 | 1998-12-22 | Chips International, Inc. | Apparatus, system and method for recording and/or retrieving audio information |
DK48092D0 (en) | 1992-04-10 | 1992-04-10 | Novo Nordisk As | APPARATUS |
US5342180A (en) | 1992-11-17 | 1994-08-30 | Ivac Corporation | Pump mechanism having a drive motor with an external rotor |
US5411487A (en) | 1992-12-07 | 1995-05-02 | Castagna; John F. | Hypodermic syringe with automatic needle cover |
US5719761A (en) | 1993-01-15 | 1998-02-17 | Alaris Medical Systems, Inc. | Configuration control system for configuring multiple biomedical devices |
US5545143A (en) | 1993-01-21 | 1996-08-13 | T. S. I. Medical | Device for subcutaneous medication delivery |
US5395340A (en) | 1993-03-15 | 1995-03-07 | Lee; Tzium-Shou | Infusion pump and a method for infusing patients using same |
DK39293D0 (en) | 1993-04-01 | 1993-04-01 | Novo Nordisk As | DISPENSES PROTECTED FOR RECYCLING |
US5261882A (en) | 1993-04-26 | 1993-11-16 | Sealfon Andrew I | Negator spring-powered syringe |
DK109293D0 (en) | 1993-09-27 | 1993-09-27 | Novo Nordisk As | APPARATUS |
US5957889A (en) | 1993-09-27 | 1999-09-28 | Novo Nordisk A/S | Displacement system for controlled infusion of a liquid |
US5816306A (en) | 1993-11-22 | 1998-10-06 | Giacomel; Jeffrey A. | Shape memory alloy actuator |
US5482446A (en) | 1994-03-09 | 1996-01-09 | Baxter International Inc. | Ambulatory infusion pump |
US5569186A (en) | 1994-04-25 | 1996-10-29 | Minimed Inc. | Closed loop infusion pump system with removable glucose sensor |
SE510420C2 (en) | 1994-11-14 | 1999-05-25 | Cma Microdialysis Ab | Infusion and microdialysis pump |
US5637095A (en) | 1995-01-13 | 1997-06-10 | Minimed Inc. | Medication infusion pump with flexible drive plunger |
US5772635A (en) | 1995-05-15 | 1998-06-30 | Alaris Medical Systems, Inc. | Automated infusion system with dose rate calculator |
US5665065A (en) | 1995-05-26 | 1997-09-09 | Minimed Inc. | Medication infusion device with blood glucose data input |
US6045537A (en) | 1995-06-02 | 2000-04-04 | Novo Nordisk A/C | Syringe with automatically withdrawable of piston rod |
US5693018A (en) * | 1995-10-11 | 1997-12-02 | Science Incorporated | Subdermal delivery device |
JP4472026B2 (en) | 1996-02-23 | 2010-06-02 | ノボ ノルディスク アクティーゼルスカブ | Syringe with electronic representation of parameters |
ATE494027T1 (en) | 1996-03-12 | 2011-01-15 | Novo Nordisk As | INJECTION DEVICE WITH ELECTRONIC DISPLAY OF THE SELECTED DOSE |
RU2180861C2 (en) | 1996-04-24 | 2002-03-27 | Ново Нордиск А/С | Injection needle |
BR9710204A (en) | 1996-07-05 | 1999-08-10 | Novo Nordisk As | Flexible piston rod |
PL330817A1 (en) | 1996-07-05 | 1999-06-07 | Novo Nordisk As | Dose establishing device |
DE19627619A1 (en) | 1996-07-09 | 1998-01-15 | Orlita Prozesstechnik Orlita G | Drive for diaphragm or piston pump for dosing of media, e.g. medicine into body |
US5947934A (en) | 1996-09-13 | 1999-09-07 | Novo Nordisk A/S | Dose display for an injection syringe |
US6379339B1 (en) | 1996-09-13 | 2002-04-30 | Nova Nordisk A/S | Syringe |
US6110149A (en) | 1996-09-13 | 2000-08-29 | Novo Nordisk A/S | Syringe |
EP0927055B1 (en) | 1996-09-20 | 2001-12-05 | Novo Nordisk A/S | Working cylinder |
WO1998033538A1 (en) | 1997-02-04 | 1998-08-06 | Novo Nordisk A/S | A device for the administration of a liquid medicament suspension |
US5851197A (en) * | 1997-02-05 | 1998-12-22 | Minimed Inc. | Injector for a subcutaneous infusion set |
US20070142776A9 (en) | 1997-02-05 | 2007-06-21 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
US6607509B2 (en) | 1997-12-31 | 2003-08-19 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
US6074372A (en) | 1997-06-09 | 2000-06-13 | Novo Nordisk A/S | Dose setting mechanism and an injection syringe having such a dose setting mechanism |
US6003736A (en) | 1997-06-09 | 1999-12-21 | Novo Nordisk A/S | Device for controlled dispensing of a dose of a liquid contained in a cartridge |
US6558351B1 (en) | 1999-06-03 | 2003-05-06 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
US6796970B1 (en) | 1997-06-17 | 2004-09-28 | Novo Nordisk A/S | Dose setting device |
EP0996476B1 (en) | 1997-07-14 | 2003-05-21 | Novo Nordisk A/S | Cylinder ampoule |
AU8333398A (en) | 1997-07-14 | 1999-02-10 | Novo Nordisk A/S | Injection member |
US6171276B1 (en) | 1997-08-06 | 2001-01-09 | Pharmacia & Upjohn Ab | Automated delivery device and method for its operation |
US5997475A (en) | 1997-08-18 | 1999-12-07 | Solefound, Inc. | Device for diabetes management |
US5919167A (en) | 1998-04-08 | 1999-07-06 | Ferring Pharmaceuticals | Disposable micropump |
US6302855B1 (en) | 1998-05-20 | 2001-10-16 | Novo Nordisk A/S | Medical apparatus for use by a patient for medical self treatment of diabetes |
TW406018B (en) | 1998-05-21 | 2000-09-21 | Elan Corp Plc | Improved adhesive system for medical devices |
EP1094857B1 (en) | 1998-07-08 | 2003-10-08 | Novo Nordisk A/S | A medical delivery device and a cartridge assembly for use in the same |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
US6558320B1 (en) | 2000-01-20 | 2003-05-06 | Medtronic Minimed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
US6248067B1 (en) | 1999-02-05 | 2001-06-19 | Minimed Inc. | Analyte sensor and holter-type monitor system and method of using the same |
DE19840965A1 (en) | 1998-09-08 | 2000-03-09 | Disetronic Licensing Ag | Device for self-administration of a product fluid |
JP4469504B2 (en) | 1998-10-08 | 2010-05-26 | メドトロニック ミニメド インコーポレイテッド | Remote trait monitor system |
US6248093B1 (en) | 1998-10-29 | 2001-06-19 | Minimed Inc. | Compact pump drive system |
US6605067B1 (en) | 1998-11-20 | 2003-08-12 | Novo Nordisk A/S | Injection needle |
US6540672B1 (en) | 1998-12-09 | 2003-04-01 | Novo Nordisk A/S | Medical system and a method of controlling the system for use by a patient for medical self treatment |
US6375638B2 (en) | 1999-02-12 | 2002-04-23 | Medtronic Minimed, Inc. | Incremental motion pump mechanisms powered by shape memory alloy wire or the like |
DE19912459C2 (en) † | 1999-03-19 | 2001-02-22 | Disetronic Licensing Ag | Medical passage device for subcutaneous injection |
DE19916876A1 (en) | 1999-04-14 | 2000-11-02 | Clemens Micheler | Medical dosing pump |
JP3613066B2 (en) | 1999-04-15 | 2005-01-26 | ソニー株式会社 | Drive device using shape memory alloy |
US6461331B1 (en) | 1999-05-21 | 2002-10-08 | Minimed Inc. | Device and method for infusion of small molecule insulin mimetic materials |
US6752787B1 (en) | 1999-06-08 | 2004-06-22 | Medtronic Minimed, Inc., | Cost-sensitive application infusion device |
US7247138B2 (en) | 1999-07-01 | 2007-07-24 | Medtronic Minimed, Inc. | Reusable analyte sensor site and method of using the same |
TW453884B (en) | 1999-09-16 | 2001-09-11 | Novo Nordisk As | Dose setting limiter |
US6381496B1 (en) | 1999-10-01 | 2002-04-30 | Advanced Bionics Corporation | Parameter context switching for an implanted device |
US6659978B1 (en) | 1999-10-04 | 2003-12-09 | Seiko Instruments Inc. | Portable dosing apparatus |
DE19947826B4 (en) | 1999-10-05 | 2006-06-08 | Disetronic Licensing Ag | Device for the metered administration of an injectable product |
US6564105B2 (en) | 2000-01-21 | 2003-05-13 | Medtronic Minimed, Inc. | Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data |
WO2001054757A1 (en) | 2000-01-28 | 2001-08-02 | Novo Nordisk A/S | A dose setting limiter |
EP1136698A1 (en) | 2000-03-17 | 2001-09-26 | Seiko Epson Corporation | Temperature difference drive unit, and electric device, timepiece and light electrical appliance having the same |
TW523415B (en) | 2000-03-24 | 2003-03-11 | Novo Nordisk As | A flexible piston rod |
US6485465B2 (en) | 2000-03-29 | 2002-11-26 | Medtronic Minimed, Inc. | Methods, apparatuses, and uses for infusion pump fluid pressure and force detection |
US6485461B1 (en) | 2000-04-04 | 2002-11-26 | Insulet, Inc. | Disposable infusion device |
US6585699B2 (en) | 2000-04-13 | 2003-07-01 | Nna/S | Drug delivery device provided with a one-way mechanism |
US6544229B1 (en) | 2000-05-01 | 2003-04-08 | Baxter International Inc | Linearly motile infusion pump |
US6533183B2 (en) | 2000-05-03 | 2003-03-18 | Novo Nordisk A/S | Coding of cartridges for an injection device |
US6692472B2 (en) | 2000-05-04 | 2004-02-17 | Novo Nordisk A/S | Injection device, a preassembled dose setting and injection mechanism for an injection device, and a method of assembling an injection device |
US6716198B2 (en) | 2000-05-18 | 2004-04-06 | Novo Nordisk A/S | Injection device |
AU2001272500B2 (en) | 2000-05-25 | 2005-06-23 | Debiotech Sa | Micromachined fluidic device and method for making same |
TW499314B (en) | 2000-05-30 | 2002-08-21 | Novo Nordisk As | A medication delivery device with replaceable cooperating modules and a method of making same |
US6547764B2 (en) | 2000-05-31 | 2003-04-15 | Novo Nordisk A/S | Double pointed injection needle |
US6663602B2 (en) | 2000-06-16 | 2003-12-16 | Novo Nordisk A/S | Injection device |
US6650951B1 (en) | 2000-06-19 | 2003-11-18 | International Business Machines Corporation | Method and insulin pump for providing a forgotten bolus warning |
US6538320B1 (en) * | 2000-06-28 | 2003-03-25 | Advanced Micro Devices, Inc. | Heat spreader having holes for rivet-like adhesive connections |
AU2001278417A1 (en) | 2000-07-14 | 2002-01-30 | Novo-Nordisk A/S | A liquid medication delivery device and a method of delivering an intended dose |
US6589229B1 (en) * | 2000-07-31 | 2003-07-08 | Becton, Dickinson And Company | Wearable, self-contained drug infusion device |
US6551798B2 (en) * | 2000-08-04 | 2003-04-22 | Battelle Memorial Institute | Method for using a yeast alpha-amylase promoter |
US6554800B1 (en) | 2000-08-09 | 2003-04-29 | Medtronic Minimed, Inc. | Compact pump motor system and dispensing process |
US6669090B2 (en) | 2000-08-10 | 2003-12-30 | Novo Nordick A/S | Electronic marking of a medication cartridge |
WO2002015965A2 (en) | 2000-08-18 | 2002-02-28 | Becton Dickinson And Company | Constant rate fluid delivery device with selectable flow rate and titratable bolus button |
US20040260233A1 (en) | 2000-09-08 | 2004-12-23 | Garibotto John T. | Data collection assembly for patient infusion system |
CA2771723C (en) | 2000-09-08 | 2016-03-29 | Insulet Corporation | Devices, systems and methods for patient infusion |
US6669669B2 (en) | 2001-10-12 | 2003-12-30 | Insulet Corporation | Laminated patient infusion device |
AU2001289589A1 (en) | 2000-09-22 | 2002-04-02 | Novo-Nordisk A/S | A medication delivery device |
CA2423717A1 (en) | 2000-10-04 | 2002-04-11 | Insulet Corporation | Data collection assembly for patient infusion system |
US6537251B2 (en) | 2000-10-05 | 2003-03-25 | Novo Nordisk A/S | Medication delivery device with bended piston rod |
US6508788B2 (en) | 2000-10-27 | 2003-01-21 | Novo Nordisk A/S | Medication delivery device with telescopic piston rod |
DE60126325T2 (en) | 2000-11-09 | 2007-11-08 | Insulet Corp., Beverly | DEVICE FOR THE TRANSCUTANEOUS DISPOSAL OF MEDICAMENTS |
US6922590B1 (en) | 2000-11-21 | 2005-07-26 | Advanced Bionics Corporation | Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion |
US7054836B2 (en) | 2000-11-30 | 2006-05-30 | Novo Nordisk A/S | Method for assisting a customer in building a build-to-order medical device |
US20020072720A1 (en) * | 2000-12-11 | 2002-06-13 | Hague Clifford W. | Rigid soluble materials for use with needle-less infusion sets, sensor sets and injection devices and methods of making the same |
ATE311811T1 (en) | 2000-12-21 | 2005-12-15 | Insulet Corp | REMOTE CONTROL MEDICAL DEVICE |
US6799149B2 (en) | 2000-12-29 | 2004-09-28 | Medtronic, Inc. | Therapy management techniques for an implantable medical device |
US6899699B2 (en) | 2001-01-05 | 2005-05-31 | Novo Nordisk A/S | Automatic injection device with reset feature |
WO2002064196A1 (en) | 2001-02-14 | 2002-08-22 | Novo Nordisk A/S | Electronically controlled injection or infusion device |
CN1556716A (en) | 2001-02-22 | 2004-12-22 | ���Ͽع�����˾ | Modular infusion device and method |
IL157561A0 (en) * | 2001-03-04 | 2004-03-28 | Sterling Medivations Inc | Infusion hub assembly and fluid line disconnect system |
EP3210637B1 (en) † | 2001-04-06 | 2021-01-27 | F. Hoffmann-La Roche AG | Infusion set |
WO2002083209A1 (en) | 2001-04-13 | 2002-10-24 | Nipro Diabetes Systems | Drive system for an infusion pump |
US6691043B2 (en) | 2001-08-28 | 2004-02-10 | Maxi-Med, Llc | Bolus calculator |
US6740072B2 (en) | 2001-09-07 | 2004-05-25 | Medtronic Minimed, Inc. | System and method for providing closed loop infusion formulation delivery |
US6827702B2 (en) | 2001-09-07 | 2004-12-07 | Medtronic Minimed, Inc. | Safety limits for closed-loop infusion pump control |
US20030055380A1 (en) | 2001-09-19 | 2003-03-20 | Flaherty J. Christopher | Plunger for patient infusion device |
US20030088238A1 (en) | 2001-09-26 | 2003-05-08 | Poulsen Jens Ulrik | Modular drug delivery system |
US6689100B2 (en) * | 2001-10-05 | 2004-02-10 | Becton, Dickinson And Company | Microdevice and method of delivering or withdrawing a substance through the skin of an animal |
US20040078028A1 (en) | 2001-11-09 | 2004-04-22 | Flaherty J. Christopher | Plunger assembly for patient infusion device |
US7291126B2 (en) | 2001-11-26 | 2007-11-06 | Nilimedix Ltd. | Drug delivery device and method |
US6736796B2 (en) | 2001-11-26 | 2004-05-18 | Nili-Med Ltd. | Fluid drug delivery device |
US7311693B2 (en) | 2001-11-26 | 2007-12-25 | Nilimedix Ltd. | Drug delivery device and method |
PT1448256E (en) | 2001-11-30 | 2006-06-30 | Novo Nordisk As | ASSEMBLY OF A SAFETY NEEDLE |
US6715516B2 (en) | 2001-12-19 | 2004-04-06 | Novo Nordisk A/S | Method and apparatus for filling cartridges with a liquid |
US6786890B2 (en) | 2002-01-25 | 2004-09-07 | Novo Nordisk A/S | Linear actuator and a medical delivery device comprising such linear actuator |
US6744350B2 (en) | 2002-02-28 | 2004-06-01 | Smiths Medical Md, Inc. | Insulin pump having missed meal bolus alarm |
US6852104B2 (en) | 2002-02-28 | 2005-02-08 | Smiths Medical Md, Inc. | Programmable insulin pump |
US6830558B2 (en) | 2002-03-01 | 2004-12-14 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
US6692457B2 (en) | 2002-03-01 | 2004-02-17 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
US6936006B2 (en) | 2002-03-22 | 2005-08-30 | Novo Nordisk, A/S | Atraumatic insertion of a subcutaneous device |
US7052251B2 (en) | 2002-04-22 | 2006-05-30 | Medtronic Minimed, Inc. | Shape memory alloy wire driven positive displacement micropump with pulsatile output |
US20050238507A1 (en) | 2002-04-23 | 2005-10-27 | Insulet Corporation | Fluid delivery device |
US6656158B2 (en) | 2002-04-23 | 2003-12-02 | Insulet Corporation | Dispenser for patient infusion device |
US6656159B2 (en) | 2002-04-23 | 2003-12-02 | Insulet Corporation | Dispenser for patient infusion device |
US20040153032A1 (en) | 2002-04-23 | 2004-08-05 | Garribotto John T. | Dispenser for patient infusion device |
US6960192B1 (en) | 2002-04-23 | 2005-11-01 | Insulet Corporation | Transcutaneous fluid delivery system |
US6723072B2 (en) | 2002-06-06 | 2004-04-20 | Insulet Corporation | Plunger assembly for patient infusion device |
US7338465B2 (en) † | 2002-07-02 | 2008-03-04 | Patton Medical Devices, Lp | Infusion device and method thereof |
WO2004007003A1 (en) | 2002-07-10 | 2004-01-22 | Novo Nordisk A/S | An injection device with a dose setting limiter |
US6945961B2 (en) | 2002-07-10 | 2005-09-20 | Novo Nordisk A/S | Injection device |
US20040010207A1 (en) | 2002-07-15 | 2004-01-15 | Flaherty J. Christopher | Self-contained, automatic transcutaneous physiologic sensing system |
US7018360B2 (en) | 2002-07-16 | 2006-03-28 | Insulet Corporation | Flow restriction system and method for patient infusion device |
EP1391794A1 (en) | 2002-07-23 | 2004-02-25 | Novo Nordisk A/S | Device with time indicating means |
WO2004009160A1 (en) | 2002-07-24 | 2004-01-29 | M 2 Medical A/S | An infusion pump system, an infusion pump unit and an infusion pump |
US20050160858A1 (en) | 2002-07-24 | 2005-07-28 | M 2 Medical A/S | Shape memory alloy actuator |
US20040019325A1 (en) | 2002-07-29 | 2004-01-29 | Medrip Ltd. | Syringe Pump |
DE10236669A1 (en) | 2002-08-09 | 2004-02-19 | Korszak, Dieter | Pen for administration of insulin injections, comprising LED to display amount to be injected, acoustic repeat and timer to give visual and acoustic indications of dosages and timings |
US7128727B2 (en) | 2002-09-30 | 2006-10-31 | Flaherty J Christopher | Components and methods for patient infusion device |
US7144384B2 (en) | 2002-09-30 | 2006-12-05 | Insulet Corporation | Dispenser components and methods for patient infusion device |
US7014625B2 (en) | 2002-10-07 | 2006-03-21 | Novo Nordick A/S | Needle insertion device |
US6690192B1 (en) | 2002-10-16 | 2004-02-10 | Pericom Semiconductor Corp. | Current-compensated CMOS output buffer adjusting edge rate for process, temperature, and Vcc variations |
JP2006504476A (en) | 2002-11-05 | 2006-02-09 | エム2・メディカル・アクティーゼルスカブ | Disposable, wearable insulin administration device, combination of the device and program control device, and operation control method of the device |
US20040116866A1 (en) | 2002-12-17 | 2004-06-17 | William Gorman | Skin attachment apparatus and method for patient infusion device |
EP1583573B1 (en) | 2002-12-23 | 2011-02-16 | Asante Solutions, Inc. | Flexible piston rod |
EP1583571B1 (en) † | 2002-12-23 | 2008-02-13 | M2 Medical A/S | Medical dispensing device for insulin |
US8016798B2 (en) | 2003-02-24 | 2011-09-13 | Integrated Sensing Systems, Inc. | Fluid delivery system and sensing unit therefor |
US7070580B2 (en) * | 2003-04-01 | 2006-07-04 | Unomedical A/S | Infusion device and an adhesive sheet material and a release liner |
US20060069382A1 (en) | 2003-04-11 | 2006-03-30 | Novo Nordisk A/S | Delivery device |
AU2004232289A1 (en) | 2003-04-18 | 2004-11-04 | Insulet Corporation | User interface for infusion pump remote controller and method of using the same |
US20050182366A1 (en) | 2003-04-18 | 2005-08-18 | Insulet Corporation | Method For Visual Output Verification |
US20050215982A1 (en) | 2003-04-30 | 2005-09-29 | Luis Malave | RF medical device |
US20040220551A1 (en) | 2003-04-30 | 2004-11-04 | Flaherty J. Christopher | Low profile components for patient infusion device |
WO2004098682A2 (en) | 2003-05-08 | 2004-11-18 | Novo Nordisk A/S | Pivotable injection needle unit |
EP1475113A1 (en) | 2003-05-08 | 2004-11-10 | Novo Nordisk A/S | External needle inserter |
ATE392223T1 (en) | 2003-05-08 | 2008-05-15 | Novo Nordisk As | INTERNAL NEEDLE INTRODUCER |
DE10327254B4 (en) † | 2003-06-17 | 2010-01-28 | Disetronic Licensing Ag | Modular infusion pump |
WO2005002649A1 (en) | 2003-07-08 | 2005-01-13 | Novo Nordisk A/S | Portable drug delivery device having an encapsulated needle |
EP1495775A1 (en) | 2003-07-08 | 2005-01-12 | Novo Nordisk A/S | Portable drug delivery device having an encapsulated needle |
EP1502613A1 (en) † | 2003-08-01 | 2005-02-02 | Novo Nordisk A/S | Needle device with retraction means |
US6899695B2 (en) | 2003-08-08 | 2005-05-31 | Hector J. Herrera | Medication security apparatus and method |
WO2005021072A1 (en) | 2003-09-03 | 2005-03-10 | Novo Nordisk A/S | Threaded rod and nut assembly |
US20050065760A1 (en) | 2003-09-23 | 2005-03-24 | Robert Murtfeldt | Method for advising patients concerning doses of insulin |
EP1527792A1 (en) | 2003-10-27 | 2005-05-04 | Novo Nordisk A/S | Medical injection device mountable to the skin |
CA2543545A1 (en) | 2003-10-21 | 2005-05-06 | Ole Christian Nielsen | Medical injection device mountable to the skin |
US7896572B2 (en) | 2003-10-30 | 2011-03-01 | Hospira, Inc. | Medical device system |
US7494481B2 (en) * | 2004-12-03 | 2009-02-24 | Medtronic Minimed, Inc. | Multi-position infusion set device and process |
US7309326B2 (en) | 2003-11-18 | 2007-12-18 | Icu Medical, Inc. | Infusion set |
WO2005072795A2 (en) * | 2004-01-29 | 2005-08-11 | M 2 Medical A/S | Disposable medicine dispensing device |
US8961461B2 (en) | 2004-05-27 | 2015-02-24 | Baxter International Inc. | Multi-state alarm system for a medical pump |
US7303543B1 (en) | 2004-12-03 | 2007-12-04 | Medtronic Minimed, Inc. | Medication infusion set |
US20090048563A1 (en) | 2004-12-06 | 2009-02-19 | Novo Nordisk A/S | Ventilated Skin Mountable Device |
US7704229B2 (en) | 2005-02-03 | 2010-04-27 | Medtronic Minimed, Inc. | Insertion device |
US20060178633A1 (en) | 2005-02-03 | 2006-08-10 | Insulet Corporation | Chassis for fluid delivery device |
US20060184104A1 (en) | 2005-02-15 | 2006-08-17 | Medtronic Minimed, Inc. | Needle guard |
WO2006097453A1 (en) | 2005-03-17 | 2006-09-21 | Novo Nordisk A/S | Securing pairing of electronic devices |
US8137314B2 (en) | 2006-08-23 | 2012-03-20 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with compressible or curved reservoir or conduit |
US20080097291A1 (en) | 2006-08-23 | 2008-04-24 | Hanson Ian B | Infusion pumps and methods and delivery devices and methods with same |
US7905868B2 (en) | 2006-08-23 | 2011-03-15 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
US9233203B2 (en) * | 2005-05-06 | 2016-01-12 | Medtronic Minimed, Inc. | Medical needles for damping motion |
WO2006123329A2 (en) | 2005-05-17 | 2006-11-23 | Medingo Ltd. | Disposable dispenser for patient infusion |
US20070093786A1 (en) | 2005-08-16 | 2007-04-26 | Medtronic Minimed, Inc. | Watch controller for a medical device |
EP1754498A1 (en) | 2005-08-19 | 2007-02-21 | Roche Diagnostics GmbH | Driving device for an injection or infusion device |
US8105279B2 (en) | 2005-09-26 | 2012-01-31 | M2 Group Holdings, Inc. | Dispensing fluid from an infusion pump system |
US7534226B2 (en) | 2005-09-26 | 2009-05-19 | M2 Group Holdings, Inc. | Dispensing fluid from an infusion pump system |
EP1933902B1 (en) | 2005-09-26 | 2014-12-17 | Asante Solutions, Inc. | Infusion pump with a drive having a ratchet and pawl combination |
US8409142B2 (en) | 2005-09-26 | 2013-04-02 | Asante Solutions, Inc. | Operating an infusion pump system |
US8475408B2 (en) | 2005-11-08 | 2013-07-02 | Asante Solutions, Inc. | Infusion pump system |
WO2007056592A2 (en) | 2005-11-08 | 2007-05-18 | M2 Medical A/S | Method and system for manual and autonomous control of an infusion pump |
PL2077128T3 (en) † | 2005-12-23 | 2011-10-31 | Unomedical As | Injection Device |
US7601147B2 (en) | 2005-12-29 | 2009-10-13 | Winston-Cook Medical Inc. | Catheter connector assemblies and methods for attaching a catheter and luer assembly |
WO2007093981A2 (en) | 2006-02-15 | 2007-08-23 | Medingo Ltd. | Systems and methods for sensing analyte and dispensing therapeutic fluid |
US7682338B2 (en) | 2006-08-23 | 2010-03-23 | Medtronic Minimed, Inc. | Infusion medium delivery system, device and method with needle inserter and needle inserter device and method |
EP3400979B1 (en) | 2006-12-22 | 2019-11-06 | Roche Diabetes Care GmbH | Systems and devices for sustained delivery of a therapeutic fluid |
US8679062B2 (en) | 2007-04-10 | 2014-03-25 | Roche Diagnostics Operations Inc. | Apparatus and method for pumping fluid |
CA2685474C (en) | 2007-04-30 | 2014-07-08 | Medtronic Minimed, Inc. | Reservoir filling, bubble management, and infusion medium delivery systems and methods with same |
US8323250B2 (en) | 2007-04-30 | 2012-12-04 | Medtronic Minimed, Inc. | Adhesive patch systems and methods |
US20080319394A1 (en) | 2007-06-11 | 2008-12-25 | Medingo, Ltd. | Portable infusion device with reduced level of operational noise |
EP2167168B1 (en) | 2007-06-25 | 2017-05-10 | Roche Diabetes Care GmbH | Tailored basal insulin delivery system |
US8002752B2 (en) | 2007-06-25 | 2011-08-23 | Medingo, Ltd. | Protector apparatus |
-
2006
- 2006-11-08 US US11/557,910 patent/US8475408B2/en active Active
- 2006-11-08 AT AT06827657T patent/ATE439155T1/en not_active IP Right Cessation
- 2006-11-08 DK DK06827657.5T patent/DK1951340T4/en active
- 2006-11-08 EP EP06827657.5A patent/EP1951340B2/en active Active
- 2006-11-08 DE DE602006008494T patent/DE602006008494D1/en active Active
- 2006-11-08 WO PCT/US2006/043599 patent/WO2007056504A1/en active Application Filing
-
2010
- 2010-06-16 US US12/817,022 patent/US8372039B2/en active Active
- 2010-06-16 US US12/817,031 patent/US8679060B2/en active Active
- 2010-06-16 US US12/817,049 patent/US8430847B2/en active Active
-
2013
- 2013-11-27 US US14/092,532 patent/US20140088557A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5672167A (en) * | 1990-05-21 | 1997-09-30 | Recordati Corporation | Controlled release osmotic pump |
US6537268B1 (en) * | 1998-06-18 | 2003-03-25 | Medtronic Minimed, Inc. | Medical infusion device with a source of controlled compliance |
US6461329B1 (en) * | 2000-03-13 | 2002-10-08 | Medtronic Minimed, Inc. | Infusion site leak detection system and method of using the same |
US7172572B2 (en) * | 2001-10-04 | 2007-02-06 | Boston Scientific Scimed, Inc. | Manifold system for a medical device |
US20030216686A1 (en) * | 2002-03-08 | 2003-11-20 | Applied Diabetes Research, Inc. | Low profile, pivotal connection infusion assembly |
US20040115068A1 (en) * | 2002-09-27 | 2004-06-17 | Steffen Hansen | Membrane pump with stretchable pump membrane |
US20040187952A1 (en) * | 2003-03-31 | 2004-09-30 | International Business Machines Corporation | Apparatus and method to enhance reservoir utilization in a medical infusion device |
US20050101933A1 (en) * | 2003-11-10 | 2005-05-12 | James Marrs | Subcutaneous infusion device and method |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11865299B2 (en) | 2008-08-20 | 2024-01-09 | Insulet Corporation | Infusion pump systems and methods |
US11147914B2 (en) | 2013-07-19 | 2021-10-19 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US11464906B2 (en) | 2013-12-02 | 2022-10-11 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US11471598B2 (en) | 2015-04-29 | 2022-10-18 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
US11065381B2 (en) | 2015-10-05 | 2021-07-20 | E3D A.C.A.L. | Infusion pump device and method for use thereof |
US10987468B2 (en) | 2016-01-05 | 2021-04-27 | Bigfoot Biomedical, Inc. | Operating multi-modal medicine delivery systems |
Also Published As
Publication number | Publication date |
---|---|
US8475408B2 (en) | 2013-07-02 |
EP1951340A1 (en) | 2008-08-06 |
DK1951340T4 (en) | 2017-05-22 |
US20070123819A1 (en) | 2007-05-31 |
US20100256564A1 (en) | 2010-10-07 |
EP1951340B1 (en) | 2009-08-12 |
ATE439155T1 (en) | 2009-08-15 |
US8679060B2 (en) | 2014-03-25 |
US20100256563A1 (en) | 2010-10-07 |
WO2007056504A1 (en) | 2007-05-18 |
US8372039B2 (en) | 2013-02-12 |
DK1951340T3 (en) | 2009-11-02 |
EP1951340B2 (en) | 2017-02-15 |
US8430847B2 (en) | 2013-04-30 |
DE602006008494D1 (en) | 2009-09-24 |
US20100256598A1 (en) | 2010-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8679060B2 (en) | Infusion pump system | |
US20150057615A1 (en) | Infusion Pump System | |
US10518028B2 (en) | Nighttime basal dosing device | |
US6852106B2 (en) | Implantable refillable and ported controlled release drug delivery device | |
EP0239244B1 (en) | Subcutaneous injection set | |
US4755173A (en) | Soft cannula subcutaneous injection set | |
US6699218B2 (en) | Transcutaneous delivery means | |
US4581020A (en) | Medication delivery device and system for percutaneous administration of medication | |
US6629949B1 (en) | Micro infusion drug delivery device | |
JP4499562B2 (en) | Infusion device and infusion method | |
US20040092865A1 (en) | Transcutaneous delivery means | |
US20100198157A1 (en) | Cannula and Delivery Device | |
US20120160848A1 (en) | Reservoir pressure equalization systems and methods | |
JPH0747136A (en) | Drug instillator with dosage recharge restriction | |
WO2021138695A1 (en) | Infusion port | |
US8430848B1 (en) | Reservoir and administration device with ratcheting mechanism | |
AU2001297716A1 (en) | Implantable refillable and rate controlled drug delivery device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: M2 MEDICAL A/S, DENMARK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MERNOE, MORTEN;CAUSEY, JAMES;WENGER, MITCHELL;AND OTHERS;SIGNING DATES FROM 20070202 TO 20070208;REEL/FRAME:039540/0661 Owner name: M2 GROUP HOLDINGS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:M2 MEDICAL A/S;REEL/FRAME:039540/0913 Effective date: 20090324 |
|
AS | Assignment |
Owner name: BIGFOOT BIOMEDICAL, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ASANTE LLC;REEL/FRAME:039827/0060 Effective date: 20150527 Owner name: ASANTE SOLUTIONS, INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:M2 GROUP HOLDINGS, INC.;REEL/FRAME:039833/0256 Effective date: 20100406 Owner name: ASANTE LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ASANTE SOLUTIONS, INC.;REEL/FRAME:039871/0771 Effective date: 20150522 |
|
AS | Assignment |
Owner name: MADRYN HEALTH PARTNERS, LP, NEW YORK Free format text: SECURITY INTEREST;ASSIGNOR:BIGFOOT BIOMEDICAL, INC.;REEL/FRAME:055583/0044 Effective date: 20210312 |
|
AS | Assignment |
Owner name: MADRYN FUND ADMINISTRATION, LLC, NEW YORK Free format text: SECURITY INTEREST;ASSIGNOR:MADRYN HEALTH PARTNERS, LP;REEL/FRAME:062702/0145 Effective date: 20230209 |
|
AS | Assignment |
Owner name: BIGFOOT BIOMEDICAL, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MADRYN FUND ADMINISTRATION, LLC;REEL/FRAME:065029/0271 Effective date: 20230922 |